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ABSTRACT  
Obesity is one of the major public health issues in the world with a rapid increase 
in its prevalence. According to the last public health report from supreme public health in 
Qatar in 2012, 71.8 % of the women were overweight compared to 68.3% of men. 
Adipocytes are where their size can vary with different food intake. The rapid expansion 
of the adipose tissue requires high vascularization to support their expansion. Branching 
of vasculature depends on properly functioning endothelial cells of the vessels. Different 
diseases including diabetes and obesity has been reported to cause defects in the 
endothelial cell function. This defect could be due to changes in nitric oxide production 
which regulate vascular contractility or production of other oxyradicals leading to damage 
to the tissue. 
Calreticulin (CRT) is a multifunctional protein localized in the endoplasmic 
reticulum of all mammalian cells. The main functions of CRT are regulation of 
intracellular Ca2+ hemostasis and chaperone. Our transgenic mouse model overexpressing 
CRT in endothelial cells (ECCRT+) showed evidence of endothelial dysfunction and 
susceptibility to obesity and diabetes as they age. Therefore, we hypothesized that 
overexpression of CRT in endothelial cells results in endothelial dysfunction that 
increases angiogenesis leading to activation of adipogenesis.   
In our study we examined changes in the phenotype of adipocytes of wild type 
(wt) and ECCRT+ mice fed either high fat (60%) or regular fat (10%) diet for different time 
points (8-24 weeks). Our results illustrated that these mice expressed lower eNOS thus 
leading to endothelial dysfunction. The Glucose tolerance test (GTT) assay illustrated that 
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ECCRT+ mice developed diabetes as they aged when on 10% fat diet. However, on high fat 
diet they failed to regulate blood glucose even at 8 weeks. Histological analysis of the wt 
and ECCRT+ mice showed significant changes in the adipocyte size and number suggesting 
a possible association between endothelial dysfunction and adipogenesis. Our study is the 
first to show an important role of endothelial dysfunction in altering adipogenesis process 
leading to the development of obesity and diabetes. Our data also highlights the 
importance of an endoplasmic reticulum chaperone in this process.   
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CHAPTER 1: INTRODUCTION  
Obesity is considered as one of the major public health issues in the world with a 
rapid increase in its prevalence reaching an epidemic proportion (Lobato et al., 2012). In 
the last WHO report published in 2012, 1.9 billion of adults 18 years and older, and 43 
million children under 5 years, were reported to be overweight. The same report illustrated 
that in total 13% of the adult population are obese, with higher percentage in women 
(15%) compared to men (11%) (WHO, 2012). Not only western countries suffer from 
obesity, gulf region also have a high prevalence of overweight and obesity among their 
population. According to the last public health report from supreme public health in Qatar 
in 2012, 71.8 % of the men were overweight compared to 68.3% of women (Figure1.1). 
Among the gulf region, Qatar has the 6th highest rate of obesity in young boys (NHS, 
2012). Moreover, the WHO survey in 2009 showed 70% of the Qatari children were obese 
because of the nutritional changes and unhealthy lifestyle (Figure 1.2). Many of the 
published studies illustrate the role of obesity in developing various diseases such as 
atherosclerosis, hypertension, insulin resistance, non-alcoholic fatty liver and cancer, all 
of which increase the rate of mortality and morbidity worldwide (Chan & Woo, 2010).  
  
   
 2 
 
 
 
 
Figure 1.1 Qatar National Health Report released in 2012, statistics showing the 
prevalence of overweight and obesity among Qatari populations (NHS, 2012). 
 
 
Figure 1.2 Qatar National Health Report released in 2012, statistics showing the 
prevalence of poor nutrition among Qatari population (NHS, 2012). 
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Adipose tissue is an important endocrine organ that maintains body energy 
hemostasis (Caruso, Balistreri, & Candore, 2010) (Trayhurn & Beattie, 2001). Adipocytes 
are active cells secreting a number of adipokines such as adiponectin, leptin and resistin 
that modulate cell metabolism. During normal development, pre-adipocytes undergo a 
process of differentiation which is known as adipogenesis. During high caloric intake, the 
size of adipocytes increase to facilitate the storage of excess product as lipid. The growing 
adipose tissue requires higher supply of oxygen and nutrients, that will be achieved 
through increasing the number or branching of the pre-existing vasculature (Lijnen, 2008, 
Bruemmer, 2012).  
Angiogenesis is defined as the growth of new blood vessels from pre-existing 
vessels within the tissues (Corvera & Gealekman, 2014). Angiogenesis is considered a 
significant process for tissue development, in adipose tissue it is important for adipose 
tissue expansion, in tumor progression it allows growth of the solid mass and provides 
means for metastasis and during wound healing it is essential for closure of the wound. 
Thus, improper angiogenesis could cause adipose tissue dysfunction, endothelial 
dysfunction and improper adipogenesis in obesity (Kolluru, Bir, & Kevil, 2012).  
A layer of endothelial cells covers the entire lumen side of the vasculature. 
Endothelium layer forms the barrier that separates the vessel wall from the blood. Vascular 
endothelium is a dynamic tissue that produces many factors therefore playing a significant 
role in controlling vascular tone, maintenance of blood circulation, controlling the blood 
coagulation and inflammatory responses (Avogaro & De Kreutzenberg, 2005).  
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Endothelial dysfunction is the inability of endothelium to maintain the vascular 
homeostasis. It is defined as the imbalance in the production of vasodilator and 
vasoconstrictor substances that are produced by the endothelium (Lobato et al., 2012). 
Endothelial cells mainly produce nitric oxide through the activity of its nitric oxide 
synthase (eNOS). Endothelial dysfunction could develop due to reduction of nitric oxide 
bioavailability that results from impaired endothelium layer and/or increased nitric oxide 
inactivation by reactive oxygen species (ROS) (Singhal, 2005). Endothelial dysfunction 
causes inability of the arteries and arterioles to ideally dilate in response to a proper 
stimulus by vasodilator on the endothelium (Witting et al., 2007).  
Previous studies suggested that Calreticulin (CRT) could play a role in vascular 
development. Mesaeli et al., 1999, showed that during mice development, CRT protein 
was highly expressed in early stages of heart and vascular development (Mesaeli et al., 
1999). CRT promoter activity within the heart and descending aorta suggest that CRT 
could have a role in regulating the formation of new blood vessels in mice (Mesaeli et al., 
1999). Originally, CRT was identified as universal Ca2+ binding protein located in the 
lumen of endoplasmic reticulum (ER). It has many vital functions including regulation of 
Ca+2 homeostasis, chaperoning in ER and cell adhesion. CRT as one of the ER chaperone 
proteins, binds to the newly synthesized proteins and supports them for correct tertiary 
structure folding (Yokoyama & Hirata, 2005). Various studies discussed the importance 
of CRT, however its role in the development of endothelial dysfunction has not been fully 
discussed.  
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Several studies showed that endothelial dysfunction can result as a consequence 
of many diseases such as diabetes, obesity and hypertension and showed that increased 
adipocyte angiogenesis affects the development of obesity (Corvera & Gealekman, 
2014)(Neels, et al., 2004) but it is not clear how endothelial dysfunction could affect the 
onset of obesity. Therefore, my study focuses on this aspect.  
 
1.1 HYPOTHESIS  
Overexpression of CRT in endothelial cells results in endothelial dysfunction 
which affects the process of angiogenesis and adipogenesis leading to the development of 
obesity.   
 
1.2 SIGNIFICANCE OF THE PROBLEM 
Obesity has reached a worldwide epidemic status. It can result in the onset of many 
other diseases such as diabetes, cardiovascular disease and cancer. It is important to 
identify the cellular mechanism of development of obesity.  The published literature has 
illustrated the onset of endothelial dysfunction as the result of obesity and diabetes. As 
part of Dr. Mesaeli’s ongoing research on vascular development, an endothelial targeted 
transgenic mouse line was generated in her lab by overexpressing CRT, an ER chaperone, 
in these cells [will be referred to as (ECCRT+)]. One of the major phenotype of these mice 
is the development of visceral obesity and diabetes.  
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The preliminary results from Dr. Mesaeli’s lab illustrated that these mice suffer 
from endothelial dysfunction. This mouse model highlighted the possible role of 
endothelial dysfunction in the development of diabetes and obesity. Thus, this mouse 
model provides a valuable tool to examine the cause and effect relationship between 
endothelial dysfunction and obesity. Initial histological analysis of the fat from these 
ECCRT+ mice showed changes in adipocyte size and number suggesting a possible 
association between endothelial dysfunction and adipogenesis. However, the exact 
mechanism of adipogenesis upon endothelial dysfunction and its correlation with CRT is 
not clear.   
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1.3 AIMS AND OBJECTIVES 
AIM 
Many studies have focused on how obesity induces endothelial dysfunction. Very 
little information is available on the vice-versa. Therefore, the aim of our study is to 
determine the cause and effect relationship between CRT, endothelial dysfunction and the 
development of obesity using the ECCRT+ mouse model.  
OBJECTIVES  
1. Characterization of adipocyte phenotype of ECCRT+ mice. 
2. Examine Endothelial dysfunction.  
3. Examine adipose tissue angiogenesis in ECCRT+ mice. 
4. Determine effect of high fat diet on ECCRT+ adipocyte phenotype. 
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CHAPTER 2. REVIEW OF THE LITERATURE 
2.1 Calreticulin 
  2.1.1 Calreticulin overview 
Originally CRT was identified as a calcium (Ca2+) binding protein that was 
isolated from endoplasmic reticulum (ER) of rabbit skeletal muscles (Ostwald & 
MacLennan, 1974). In 1989, the coding gene of this protein was cloned and named 
Calreticulin (CRT), showing the localization and functional characteristic of this protein 
(Mesaeli et al., 1999) (Michalak et al., 1999). The predicted molecular weight of CRT is 
46 KDa but it appears as a 62 KDa protein on SDS-acrylamide gel due to high number of 
acidic amino acids at the C terminus of the protein (Michalak et al., 1999). Initial studies 
showed the localization of CRT to the ER but some reports also  suggested  its localization 
on the surface and in the nucleus of the cells (Wada et al., 1995) (Dupuis et al., 1993) 
(White, Zhu, & Tanzer, 1995) (Dedhar, 1994) (Arnaudeau et al., 2002). This is still a 
controversial topic in the field and more studies in intact cells and sophisticated imaging 
techniques needs to be conducted to confirm the other localization of the protein.  
In addition to the regulation of Ca2+ homeostasis, CRT also functions as an ER 
lectin like chaperone. CRT as one of the chaperone proteins in the ER, binds to newly 
synthesized proteins and support their correct tertiary structure folding (Yokoyama & 
Hirata, 2005). CRT has been shown to be involved in ER stress and injury response 
(Hebert & Molinari, 2007) (Jeffery et al., Raghavan, 2011). Furthermore, it was shown 
that CRT is involved in the regulation of cell migration, and adhesion (Gold et al., 2010).  
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2.1.2 Structure 
CRT gene in human is composed of 9 exons and 8 introns (Yokoyama & Hirata, 
2005). It is located on chromosome 19 in human and chromosome 8 in mice (Rooke et al.,  
1997) (McCauliffe et al., 1992). Although forming 3-D structure for CRT has been 
challenging due to the inability to crystalize the protein, its conformation has been 
identified using X-ray structure (Michalak, et al., 2002)(Giraldo et al., 2010).  CRT has 
three structural domains including, N-terminal domain that is important in protein-protein 
interaction, Proline-rich area known as P domain with internal repeats that is involved in 
protein-protein interaction and  also binds Ca2+, and the C-terminal domain which has a 
vital role in regulating Ca2+ homeostasis and ends with KDEL (Lys-Asp-Glu-Leu) 
retention signal of ER and (Jiang et al., 2014) (Figure 2.1).  
The N-domain and P-domain of CRT share high homology to N and P domains of calnexin 
and based on this similarity it has been predicted to have a globular structure (Roderick, 
et al., 2000). N-terminus is also called lectin domain due to its binding to carbohydrate 
residues on the newly synthesized peptides (Schrag et al., 2001). The P domain contains 
tandem repeats of two proline rich sequence motifs which interact with one another in a 
head-to-tail fashion (Schrag et al., 2001). The structural similarities of the P domain 
between the CRT and calnexin was confirmed using NMR reconstruction (Leach et al., 
2002). Moreover, the primary polypeptide and carbohydrate binding site of N-domain of 
CRT along with the P-domain, is responsible for the chaperone function of CRT (Leach 
et al., 2002). 
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The C-domain of CRT contains a large number of acidic amino acid residues 
(glutamic acids) that are characterized by their ability to bind Ca2+ with high capacity and 
low affinity (Baksh & Michalak, 1991). The C-domain is considered highly susceptible 
to proteolytic cleavage due to the lack of complex tertiary structure (Jorgensen et al., 
2005). The highly negative charge of this domain has prevented the ability to crystalize 
CRT and obtain the full protein crystal structure. CRT has been shown to be 
phosphorylated on serine-threonine residues and arginylated by arginyl-tRNA protein 
transferase at the cell surface that increases susceptibility of the cell to apoptosis (Decca 
et al., 2007).  
 
 
 
 
Figure 2.1 Schematic representation of the structural domains of calreticulin 
protein. The protein consists of three functional domains including: N-domain, P-
domain, and C-domain. The KDEL ER retentional peptide at C-terminal and signal 
sequence at N-terminal. Modified figure from  (Michalak et al., 1999). 
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2.1.3 Function 
2.1.3.1 Calreticulin as Chaperone 
The complex structure of CRT demonstrates how it can have several functions in 
and out of the cell, as a chaperone and as a regulator for the quality of the newly 
synthesized proteins (Michalak et al.,2009). ER is the place where polypeptides interact 
with the molecular chaperones and thiol oxidoreductases after translation. Inside the ER, 
chaperones are grouped according to their functions. Lectin chaperones such as Calnexin 
and CRT are involved in recognizing and folding the proteins that contain certain pattern 
of sugar moieties. Classical ER chaperones, includes several subfamilies, such as Hsps 
(40, 60, 70, 90, and 100 KDa) that are transcribed by the induction with heat shock. 
Another subfamily known as GRP78/BiP and Grp94 are glucose regulated proteins (Spiro 
et al.,1996) (Helenius, 2001).  
In ER, some proteins can fold using general chaperones, however, due to the 
complex structure of some proteins, they require special assistance. This assistance is 
provided through chaperones known as substrate specific chaperones, which include 
receptor associated proteins (RAP) that ensure the proper folding of proteins and prevent 
the aggregation of low density lipoprotein receptors (Hebert & Molinari, 2007). Hsp47 
which is a collagen specific chaperone is required for retaining the triple helical structure 
of collagen by interacting with other chaperones such as CRT and Calnexin (Spiro et al., 
1996).   
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2.1.3.2 Calreticulin/Calnexin cycle 
Calnexin and CRT are homologous lectin chaperones that interact with the newly 
synthesized glycoproteins in the ER. In fact, the role of this cycle is to selectively engage 
newly synthesized glycoproteins. The functional process of these chaperones starts once 
the polypeptide is recognized by CRT and calnexin to ensure the proper folding of these 
proteins through the cycle. Prolonged interaction between the protein and calnexin/CRT, 
will subject the protein to degradation via ER associated degradation (ERAD)(Hebert & 
Molinari, 2007). On the other hand, proper folding of proteins will allow them to be 
transported out the ER to the Golgi apparatus for further processing.  
Glycosylation of newly synthesized proteins acts as a signal for enhanced folding 
and quality control and/or for the degradation of misfolded proteins (Hebert & Molinari, 
2007). CRT, which is a soluble protein, associates with glycans that emerge deeper into 
the ER lumen while calnexin binds to glycans found in the membrane proximal domains 
(Trombetta et al.,1996). Calnexin binds transiently to most glycoproteins whereas CRT 
binds to a more restricted set of glycoproteins (Keller et al., 1998) (Peterson et al., 1995). 
Given that calnexin and CRT bind monoglucosylated glycans with micromolar affinities, 
their chaperone binding cycles are controlled via the glucosidases and glucose-transferase 
that dictate the composition of the carbohydrate on the maturing glycoproteins in the ER 
(Kapoor et al., 2003).  
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Monoglucosylated N-glycans mediate initial association of folding polypeptides 
with calnexin and/or CRT that exposes them to the glycoprotein dedicated oxidoreductase 
ERp57 (Hammond et al., 1994). ERp57 is an additional component in the calnexin/CRT 
cycle. It is a member of the PDI family of proteins (Oliver et al., 1997). ERp57 catalyzes 
rearrangements of disulfide-bonds within the substrate proteins, but does not recognize 
their glycon moiety (Zapun et al., 1998). It is likely that most glycopolypeptides are 
released from calnexin/CRT/ERp57 in a native, transport competent state (Frickel et al., 
2002). They are rapidly deglucosylated and partially demannosylated and eventually 
sequestered in transport vesicles that leave the ER (Hebert & Molinari, 2007). For a 
fraction of the newly synthesized glycoproteins, folding is not completed in a single round 
of association with calnexin/CRT. The folding intermediate released from the lectin 
chaperones is deglucosylated, but its forward transport is inhibited by glucose transferase 
1. Glucose transferase 1 adds back a glucose residue only to glycoproteins with nearly 
native conformation. These rebind to calnexin/CRT and are subjected to additional folding 
attempts likely to consist in disulfide reshuffling. Glycopolypeptides released from 
calnexin/CRT and displaying major folding defects are ignored by glucose transferase 1, 
rather, they attract BiP (Julio et al., 2004). They are extensively demannosylated and 
dislocated across the ER membrane for proteasome mediated degradation (Caramelo et 
al., 2003).  
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A study conducted by Pipe and colleagues demonstrated that some coagulation 
factors binds to different chaperones despite the structural similarity or glycosylation 
patterns. For instance, factor VIII interacts only with calnexin while Factor V interacts 
with both CRT and calnexin. In addition, CRT knockout cells (or CRT deficient ) cells 
was shown to have a slight decrease in folding efficiency while cells with calnexin 
deficiency completely prevents folding of some proteins, such as hemagglutinin (Pipe et 
al.,1998). Moreover, CRT deficient cells have increased calnexin similarly calnexin 
deficient cells express higher level of CRT suggesting that these chaperones can 
compensate each other’s function (Molinari et al., 2004). Remarkably, both CRT and 
calnexin knockout cells express higher levels of GRP78 which is known as the master 
regulator of the ER stress, suggesting that other ER chaperones may be compensating for 
the loss of CRT or calnexin, at least in vitro (Molinari et al., 2004). However, deletion of 
CRT system in vivo has been shown to  cause  embryonic death resulted from a lesion in 
cardiac development as shown by Mesaeli et al. (Mesaeli et al., 1999). A study conducted 
by Kraus, et al. in 2010 showed that calnexin knockout mice suffer from  myelinopathy 
with no apparent effects on other systems (Kraus et al., 2010). However, Denzel et al, 
showed that calnexin deletion caused severe growth and motor disorders, and premature 
death (Denzel et al., 2002).  These lethal outcomes could confirm that the calnexin/CRT 
chaperone system plays a vital role during protein biogenesis which may be restricted to 
specific organs or developmental phases. 
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2.1.3.3 Calreticulin and Ca2+ homeostasis  
CRT plays a vital role in Ca2+  homeostasis within the cell (Wada et al., 1995). 
Ca2+ signaling is very important in regulating cell signaling, cell survival, induction of ER 
stress and apoptosis (Michalak et al., 2009). Therefore, it is crucial that ER and 
cytoplasmic Ca2+ are well controlled. The level of Ca2+ is sustained by an on/off stimulus 
which promotes Ca2+ uptake and release in the cytoplasm. The regulation of cytoplasmic 
Ca2+ is operated through different channels such as; receptor operated channels and 
inositol triphosphate (IP3)(Berridge et al., 2000a). Once Ca2+ is released from these 
channels, it will be removed from the cytoplasm through sarco-endoplasmic reticulum 
Ca2+ ATPase (known as SERCA pump) into the ER.  Following the reuptake, Ca2+ in the 
ER can be either free or bound to Ca2+ binding proteins (including many chaperons) such 
as CRT since it has high Ca2+  binding capacity (Berridge et al., 2000b).  
Reduction in CRT level, decreases the capacity of Ca2+ storage of the cells that 
leads to accumulation of misfolded proteins, inhibition of ER Golgi trafficking which 
affects chaperone’s functions (Peters & Raghavan, 2011). On the other hand, several 
studies demonstrated that overexpression of CRT increase the Ca2+ storage in the ER with 
no effect on the cytoplasmic Ca+2 level (Opas et al., 1996). For instance, Mery et al.,  
showed that CRT overexpression in L fibroblast cell lines increased Ca2+ content by 
1.5+_0.2 fold (Mery et al., 1996). Furthermore, Arnaudeau et al., demonstrated that 
overexpression of CRT increased the luminal Ca2+ level in ER because of enhanced Ca2+ 
binding to its C-domain (Arnaudeau et al., 2002).  These authors suggested a correlation 
between ER and mitochondria in some disease state that decreases the mitochondrial Ca2+ 
content and membrane potential in CRT overexpressing cells  (Arnaudeau et al., 2002). 
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In addition, overexpression of CRT has been reported to enhance the inactivation and 
degradation of SERCA2a in cells under oxidative stress, suggesting a role for CRT 
regulation of Ca2+ homeostasis in the onset of myocardial disease (Ihara et al., 2005).  
2.1.3.4 Calreticulin and ER stress  
As previously mentioned, CRT is one of the ER chaperone proteins that works to 
ensure the proper folding of the newly synthesized proteins and their transportation from 
the ER into their final destination within the cell. Equilibrium in the cell is achieved 
between the nascent polypeptide numbers and ER chaperone numbers that are available 
to assist in folding  (Bueter et al., 2009). When misfolded proteins accumulate in ER, 
protein translation increases, Ca2+ homeostasis is altered, as well other functions of ER 
will be affected thus resulting in the onset of ER stress. Under stress conditions like 
hypoxia, oxidative stress or heat shock, specific signaling pathways are activated that are 
known as unfolded protein response (UPR).  
For the cells to overcome the stress condition they will activate a defense 
mechanism to repair the improper folded proteins, inhibit the synthesis of new proteins, 
and increase ER chaperone levels to resume the normal function of the cell (Sambrooks 
et al., 2012). Through the UPR signaling pathways, cells are induced to produce pro-
apoptotic proteins and generate granules known as stress granules (Sambrooks et al., 
2012). If ER stress persist, cells will be triggered to undergo apoptosis, however, in case 
of cancer, cells will resist apoptosis and tumor will form (Carpio et al., 2010). Under the 
stress conditions, Ca2+ is lacking and CRT acts as one of the pro-apoptotic proteins in its 
argynilated form (Ozcan & Tabas, 2012). CRT is argynilated through arginyl-tRNA 
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protein transferase (ATE) as part of UPR in which it is recruited by stress granules to 
activate apoptosis (Jeffery et al., 2011). Recent study has shown that ER stress induced 
apoptosis or ER stress is involved in different types of diseases such as cancer, 
neurodegeneration, type 2 diabetes, and atherosclerosis (Ozcan & Tabas, 2012).  
2.1.3.5 Role of ER Stress in Obesity  
There is a growing body of evidence indicating a link between ER stress and 
obesity, insulin resistance, type 2 diabetes, and fatty liver (Boden & Merali, 2011)(Sharma 
et al., 2008). It is widely known that excess nutrient intake is the main cause for obesity, 
and several recent studies have implicated ER stress as an early consequence of nutrient 
excess along with increased demand for protein synthesis to assist metabolism, local 
glucose deficiency due to insulin resistance, and decreased vascularization (Gregor & 
Hotamisligil, 2007a) (Achard & Laybutt, 2012)(Ozcan et al., 2004). This leads to 
accumulation of excess lipid in hypertrophied adipocytes, and abnormal energy changes 
observed in obesity may be a chronic stimuli causing ER stress (Fu et al., 2011). As 
mentioned in the above section, excess accumulation of unfolded protein aggregates will 
activate a process known as UPR in which also functions as regulator for the lipid 
metabolism under ER stress (Sambrooks et al., 2012)(Gregor & Hotamisligil, 2007b) 
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During ER stress, chaperone proteins play an important role in compensating for 
the correct folding of the newly synthesized proteins. Under quiescent or non-stressed 
conditions, a ubiquitous ER chaperone termed BiP or GRP78 acts as a master regulator of 
the UPR by binding to and inactivating these ER stress sensors (Basseri, et al., 2009). 
However, under conditions of ER stress, GRP78 dissociates from these sensors in order 
to interact and assist in the folding of luminal misfolded proteins thus activating UPR 
(Basseri, et al., 2009)(Prattes et al., 2000). Other chaperones such as disulfide isomerase 
(PDI), calnexin, the Hsp70, ERp29, CRT, and the peptidyl propyl isomerase family also 
play a role in the UPR process but the exact mechanism for each chaperone in relation to 
obesity is still unclear. In our preliminary data for another study in the lab we have 
observed a significant increase in the splicing of XBP-1 to sXBP-1 (one of the ER stress 
sensor pathways) suggesting the onset of ER stress upon overexpression of CRT (Lab’s 
un-published data). 
A study conducted by Basseri et al., hypothesized that during adipogenesis UPR 
activation would allow the cells to manage ER stress which exists due to the elevation of 
the protein load and lipid biosynthesis (Basseri et al., 2009). In this study, the authors 
showed that during differentiation of the 3T3-L1 preadipocytes, UPR pathways is 
activated and there were an increase in the expression of the ER chaperone GRP78 and if 
3T3-L1 cells were treated with the ER stress inhibitor 4-PBA, adipogenesis was blocked 
(Prattes et al., 2000)(Chen et al., 2016) (Basseri et al., 2009).  
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Previous studies have suggested that ER stress may be activated in the 
subcutaneous fat of obese human due to excess nutrient intake (Boden, 2009). In these 
individuals, the adipose tissue has to uptake and store excess calories as fat and, hence, 
need to increase the synthesis of many proteins to meet this challenge. The massive 
expansion of the adipose tissue and the overwhelming need for increased protein synthesis 
could further contribute to the induction of ER stress. However, the exact mechanism and 
the role of ER chaperones specifically CRT in this process in vivo is still not clear.   
2.2 Adipogensis/Angiogenesis    
  2.2.1 Adipose Tissue Structure and Functions  
Although adipose tissue functions as a major storage site for fat, it is also involved 
in several physiological processes; including secretion of different angiogenic factors, 
expression of hormone receptors, cytokines and secretion of several adipokines (Lemoine 
et al., 2013). The amount of fat storage distribution throughout the body and their role in 
physiological processes varies among different species and adipose depots (Tchkonia et 
al., 2013). Adipose tissue depots can be distinguished by their architecture as Brown or 
White adipose tissues. They can also be categorized by their localization to abdominal, 
subcutaneous, etc.; and their secretion of different adipokines (Sierra-Honigmann, 1998).  
Adipose tissue consists of a heterogeneous mixture of mature adipocytes 
surrounded by a stromal vascular cell fraction containing pre-adipocytes, pericytes, 
macrophages, endothelial cells, fibroblasts, progenitor and mesenchymal stem cells (Han 
et al., 2015). Active cells of adipocyte secrete a number of adipokines such as adiponectin, 
leptin and resistin that modulate cell metabolism (Cao et al., 2001). The level of 
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expression of adipokines correlates negatively or positively with the adipose mass. The 
released adipokines not only send signals to the brain and other organs for adipose tissue 
replenishment, and appetite regulation but also, they participate in the angiogenic process 
(Rupnick et al., 2002).  
The two subtypes of adipose tissue, white and brown, are significantly vital. The 
main function of white adipose tissues is triacylglycerol (TG) storage when there is excess 
energy intake, then release of this energy in the form of fatty acids under the conditions 
of lack of energy (Miettinen et al., 2008a). However, brown adipose tissues that are rare 
in adult human are essential for production of body heat for newborn babies (Gregoire et 
al., 1998). Various studies demonstrated that an embryonic stem cell precursor produce 
adipocyte lineage with differentiation capacity into the mesodermal cell types of 
chondrocytes, osteoblasts, myocytes and adipocytes (Konieczny & Emerson, 1984). 
Adipoblasts belong to the adipogenic lineage, become pre-adipocytes and in a suitable 
environment it differentiates into mature lipid-storing and lipid-synthesizing adipocytes 
(Katz et al., 1999) (Figure 2.2). The new fat cells are produced from the precursor cells 
and continue throughout the lifespan. Adipocytes are considered as one of the few cells 
where their size can vary under physiological conditions (Farnier et al., 2003). Adipose 
tissue grows as they store excess energy intake. Adipose tissue expands in two  ways, by 
increasing in adipocyte size (Hypertrophy) or increasing in adipocyte numbers 
(Hyperplasia). The phenotype of adipose tissues is influenced by the interaction of diet 
and genetics (Jo et al., 2009). Hypertrophic expansion of adipose tissue is often observed 
with increase in caloric intake such as in high fat diet. Hyperplastic growth of adipose 
tissues appears at early stages of development prior to hypertrophy to meet the needs of 
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lipid storage. As the size and number of adipose tissues varies, their molecular and 
physiological properties will show differences. This in turn can affect the metabolite 
profile in the circulation.  
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Figure 2.2 Process of adipocyte development and differentiation. In response to several 
transcription factors and signals, the pluripotent mesenchymal stem cells can form 
preadipocytes, myocytes, or osteoblasts depending upon these various promoters. Modified 
figure from (Garg, 2011) 
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2.2.2 Adipose Tissue Angiogenesis  
Adipose tissue is a highly vascularized tissue (Lemoine et al., 2013) (Lijnen, 
2008). The vascular networks play a vital role in the adipogenesis process. The vasculature 
of adipose tissue provide oxygen, growth factors, nutrients, and cytokines to the 
progenitor cells that are differentiated into pre-adipocytes and vascular endothelial cells 
(Tang et al., 2008). During embryonic development, both arteriolar differentiation and 
changes in extra-cellular matrix (ECM) precede differentiation of adipocytes. However, 
later during development of adipose tissue, throughout the whole life, it seems that 
adipocytes themselves drive the development and maintenance of their blood vessels 
(Mandrup et al., 1997). To adapt to changes in the size and metabolic rate of adipose 
depots, adipose vasculature requires constant regulation by several angiogenic 
modulators.   
Adipocytes regulate angiogenesis by cell to cell contact and by adipokines 
secretion. For instance, adipocytes secrete pro-angiogenic growth factors like fibroblast 
growth factor (FGF), vascular endothelial growth factor A (VEGF-A), and leptin (Xue et 
al., 2009).  They can also secret antiangiogenic factors including thrombospondin-1 (TSP-
1), or other angiogenic modulators such as plasminogen activator inhibitor or adiponectin 
(Xue et al., 2009). The ratio of all these factors at any time will determine the angiogenic 
phenotype in the adipose tissue (Xue et al., 2009).   
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2.3 Endothelial Dysfunction  
Vascular endothelial cells form the inner barrier of the vessel wall are responsible 
for maintaining the vascular vasodilation and constriction (Caballero, 2003). Endothelial 
dysfunction is defined as inability of the vascular endothelium layer to perform its 
function of regulating blood clotting and controlling relaxation of vascular wall. The cause 
of this dysfunction is the imbalance in the production and or release of vasodilators and 
vasoconstrictors affecting the narrowing and widening of the blood vessels (Lobato et al., 
2012). Some of the factors responsible for the imbalance are; reduced production of nitric 
oxide, over-expression of adhesive molecules, over-expression of chemokines and 
cytokines, and an increase in the generation of reactive oxygen species in the endothelium 
(Kolluru et al., 2012).  
Defect in the endothelial cell function has been shown to result as a consequence 
of different diseases such as obesity, diabetes, high blood pressure (Singhal, 2005). 
Studies examining this dysfunction with obesity showed that in obese people there is a 
direct correlation between the obesity and efficiency of endothelium vasodilators release 
(Lobato et al., 2012). As already mentioned, an increase or decrease in the generation of 
the reactive oxygen species is one of the main causes of endothelium dysfunction. These 
factor specifically are linking obesity to endothelial dysfunction (Adya et al., 2015). 
For maintaining vascular contractility, endothelial cells generate nitric oxide 
through activation of endothelial nitric oxide synthase (eNOS). Altered eNOS generation 
could contribute to the onset of endothelial dysfunction (Montezano & Touyz, 2012). 
Uncoupling of eNOS is a major contributor for the generation of the reactive oxygen 
species that result in decreased nitric oxide (NO) bioavailability (Montezano & Touyz, 
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2012). The fluctuation in the balance of NO and reactive oxygen species in the endothelial 
cells can influence the adipocyte cells leading to the storage of fats in fat tissues and the 
impairment of adipocytes which may lead to obesity (Lijnen, 2008). Furthermore, 
decrease in NO production will influence the contractility of the vascular wall thus 
affecting blood flow. Previous preliminary research in Dr. Mesaeli lab on the mesenteric 
artery function of ECCRT+ mice showed a significant reduction in the relaxation of 
mesenteric artery in response to acetylcholine stimulation (Figure 2.3). These studies also 
illustrated  that addition of NO donor (SNP) could recover the relaxation of the mesenteric 
artery of ECCRT+ mice (Figure 2.4) which suggest a defect in the endothelial cells on the 
vascular smooth muscle cells. These data suggest the onset of endothelial dysfunction 
upon overexpression of CRT in the endothelial cells. Based on the previous publication 
we suggest that endothelial dysfunction in the ECCRT+ mice plays an important role in the 
increased obesity in these mice. 
Insulin resistance in endothelium layer due to endothelial dysfunction was shown 
to increase the formation of fat leading to obesity (Kim et al., 2006) . This hormone plays 
a major role in maintaining the glucose levels in the body, regulating the metabolism of 
proteins, lipids, and carbohydrates, thus affecting tissue development (Wilcox, 2005). 
Several studies have illustrated the role of insulin in vessel wall to be mediated via NO 
release leading to vasodilation (Potenza et al., 2005)(Montagnani et al., 2002)(Zeng et al., 
2000). Vasodilation increases blood flow through the vessels leading to glucose uptake 
by target tissue including the skeletal muscle (Potenza et al., 2005). Insulin resistance and 
direct obesity correlate with dysfunction of endothelium (Prieto et al., 2014). 
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Diabetic patients often exhibit less supply of blood to some organs or parts of the 
body, because of the reduction in the angiogenic growth factors (Kolluru et al., 2011). 
During endothelial dysfunction, a considerable reduction in the level of NO was observed 
due to an increase in the superoxide anion which results in reducing the effect of angiogenic 
growth factors (Onat et al., 2012). A focus on the effect of NO on angiogenesis is evident 
in the healing of diabetic wounds (Y. Cao, 2013). Angiogenesis plays an important role in 
wound healing but in the case of diabetic patient wound healing is difficult due to 
impairment of the epithelial layer (Y. Cao, 2013) 
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Figure 2.3 Effect of Acetylcholine on relaxation of mesenteric arteries (third branch) 
isolated from ECCRT+ as compared to wt mice. Data were collected from pressure 
myography assay. As shown there was a significantly lower relaxation of mesenteric 
arteries in response to acetylcholine treatment suggesting either defect in NO production 
or defect in smooth muscle function. 
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Figure 2.4 Effect of Sodium nitroprusside (SNP, NO donor) on Acetylcholine mediated 
relaxation of mesenteric arteries (third branch) isolated from ECCRT+ as compared to wt 
mice. Data were collected from pressure myography assay. As shown there was no 
difference in the relaxation of mesenteric arteries isolated from ECCRT+ mice as compared 
to the wt mice. This suggest that there is no defect in NO in smooth muscle function of 
these mice. 
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CHAPTER 3. MATERIALS AND METHODS:  
3.1 MATERIALS AND REAGENTS  
Material used in research included in the current thesis were of highest Molecular 
Biology grade and are listed in Table 3.1 to 3.6.  All tables contain a list of materials/kits 
and their sources and their catalogue numbers (where applicable). 
 
Table 3.1 LIST OF KITS USED IN THIS STUDY  
 
Items Company Part Number 
Phire Tissue Direct PCR Master 
Mix Kit 
Thermo Fisher Scientific F170S 
PierceTM BCA Protein Assay Kit Thermo Fisher Scientific 23227 
 
 
Table 3.2 LIST OF ANTIBODIES USED IN THIS STUDY 
 
Items Company Part Number 
Rabbit HA Epitope Tag  Rockland 600-401-384 
Rabbit Anti-eNOS  NeoMarkers PA1-037 
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Table 3.3 LIST OF REAGENTS USED IN THIS STUDY 
 
Item Company Part Number 
Precision Plus ProteinTM Dual Color 
Standard 
Bio-Rad 161-0374 
Ponceau S Stain Sigma P3504-100G 
DEPEX Mounting Media, Electron 
Microscopy Sciences 
Electron Microscopy Science 100496-550 
O.C.T.™ Compound Tissue-Tek-Science Service 4583 
Paraformaldehyde, Prills, 95% Sigma 441244-3kg 
Xylene Sigma 534056-1L 
Hydrochloric Acid Sigma 25814-500mL 
Absolute Ethanol VWF 20821-321 
Eosin Y di-sodium Sigma E4382-100G 
Hematoxylin Sigma H9627-25G 
Dulbecco's phosphate-buffered saline 
(DPBS)-1XPBS 
Thermo Fisher Scientific 14190136 
Non-Fat Skim Milk Regilait  
Tween®20 Sigma P9416-100mL 
SuperScript™ II Reverse 
Transcriptase 
Thermo Fisher Scientific 18064014 
RNaseOUT™ Recombinant 
Ribonuclease Inhibitor 
Thermo Fisher Scientific 10777019 
Oligo(dT)12-18 Primer Thermo Fisher Scientific 18418012 
ProLong™ Gold Antifade Mountant 
with DAPI 
Thermo Fisher Scientific P36935 
Power SYBR® Green PCR Master 
Mix 
Thermo Fisher Scientific 4388869 
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Table 3.4 LIST OF INUSTRUMENT USED IN THIS STUDY 
 
 
 
Table 3.5 LIST OF SOFTWARE USED IN THIS STUDY 
 
 
 
 
 
 
Items Company Part Number 
Axiovision ZEISS Microscopy Carl ZEISS Microscopy 490035-0041-000 
Tissue Processer Cryostat-
Frozen LEICA CM 3050S 
LEICA     14047033518 
Tissue Processer Microtome-
Paraffin LEICA RM 2255 
LEICA     1492255UL01 
Licor odyssey CLX-Infrared Licor Biotechnology 
    926-75001 
 
Glucose measurement machine  One Touch Ultra-soft     Y197004 
Confocal Axiovision ZEISS 
Microscopy 
Carl ZEISS Microscopy  
Items Company 
LI-COR® Image Studio™ Lite Software Licor Biotechnology 
Axiovision Software SE64 Rel.4.8.2 Carl ZEISS Microscopy 
ZEN Microscope Software  Carl ZEISS Microscopy 
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Table 3.6 LIST OF LAB SUPPLIES USED IN THIS STUDY 
 
Items Company Part Number 
Disposable Base Molds 
Thermo Fisher 
Scientific 
41740 
Superfrost ®Plus Micro Slide VWF 48311-703 
96 Well Clear Flat Bottom TC-Treated 
Culture Microplate 
FALCON 353027 
Nitrocellulose membrane  Life Science  66485 
0.5 ml individual PCR tubes with 
attached flat caps 
USA Scientific  1615-5510 
TipOne® 0.1-10 µl Filter Pipet Tips USA Scientific 1121-3810  
TipOne®1-20 µl Beveled Filter Pipet 
Tips 
USA Scientific 1120-1810  
TipOne®1-200 µl Graduated Filter 
Pipet 
USA Scientific 1120-8810  
TipOne® 101-1000 µl Filter Pipet Tips USA Scientific 1126-7810  
Blood EDTA Tubes 1.3ml K3E Sarstedt 41.1395.105 
Glucose Strips  One Touch Ultra-soft  2730-055 
MicroAmp™ Fast Optical 96-Well 
Reaction Plate with Barcode, 0.1 mL 
Thermo Fisher 
Scientific 
4346906 
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3.2 METHODS  
3.2.1 Ethical approval  
This study included animal samples, so the ethical approval has been obtained 
from the Institutional Animal Care and Use Committee (IACUC) in Weill Cornell 
Medicine in Qatar (WCM-Q).  
3.2.2 Generation of mice model (ECCRT+) - Tie2-CRT transgenic mice 
The main mouse model used in my study was overexpressing CRT in endothelial 
cells and was developed in Dr. Mesaeli’s lab in Canada. To direct CRT expression to 
endothelial cell, Tie2 promoter which is an endothelial specific promotor was used. CRT 
cDNA was cloned sandwiched between the Tie2 promoter and Tie2 enhancer as shown in 
(Figure 3.1). To differentiate between the exogenous and endogenous CRT, hemagglutinin 
tag (HA-tag) was cloned at the C-terminus of the CRT cDNA upstream of the KDEL ER 
retention signal sequence in CRT cDNA. Previous research in the lab showed that this 
cDNA of CRT has the same localization as endogenous CRT and was able to reinstitute 
CRT function in CRT knockout cell line, therefore it was functioning correctly. The 
plasmid was then digested and purified using gel extraction. The transgene was then 
injected into the wt oocytes, as a result, eight different lines of ECCRT+ were generated and 
their genotyping was confirmed by PCR. Each line was from a separate oocyte injection. 
The phenotype of these mice was examined overtime and they showed very similar 
phenotype. 
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3.2.3 Generation of mice model (Cdh-ECCRT+ -EGFP) transgenic mice 
To examine the changes of angiogenesis in ECCRT+ mice in vivo, we generated a 
mouse line which overexpressed CRT and EGFP in the endothelial cells. To label all the 
endothelial cells with EGFP, we purchased Cdh-Cre and B6.129(Cg)-
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (ROSA-EGFP for short) mice from Jackson 
Laboratories USA. ROSA-EGFP mice express Flox-Stop-EGFP caste and can be used to 
label different cells in live mice with EGFP when they are crossed with a specific Cre mice. 
We bred these with Cdh-Cre at our Vivarium core at WCM-Q. This resulted in the 
generation of mice Cdh-EGFP mice in which Cre is activated in endothelial cells and thus 
excising Floxed STOP signal from EGFP leading to expression of EGFP in the endothelial 
cells only. The Cdh-EGFP mice were then bred with ECCRT+ mice to generate the Cdh- 
ECCRT+-EGFP mice. These crossbred mice will express EGFP and overexpress CRT in the 
endothelial cells. Tissue were collected from the Cdh- ECCRT+ -EGFP mice and Cdh-EGFP 
mice (control mice) for examining in vivo angiogenesis. Tissue was then fixed and 
processed for cryo-sections as described below. The fluorescent signal in the vasculature 
of mice was captured by confocal microscopy. The comparison of the experimental and wt 
will be easier and less time consuming than using the other immunohistochemical 
techniques.  
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3.2.4 Genotyping of the wild-type and transgenic mice (wt, ECCRT+, and Cdh-ECCRT+ -
EGFP) 
3.2.4.1 Polymerase chain reaction (PCR) analysis  
To confirm the genotype of ECCRT+ transgenic mice, Cdh-EGFP and Cdh-ECCRT+-
EGFP, we used a phire tissue direct PCR master mix kit (Thermo-Scientific) following the 
manufacture protocol. Briefly, tip of the mouse tail was clipped using a sharp blade from 
different mice and placed in a mixture of dilution buffer and DNA Release provided in the 
kit. Samples were incubated for 5 minutes at room temperature then were preheated using 
heat block for 10 minutes. The samples were then centrifuged, and the supernatant was 
collected. A total of 1µL of the genomic DNA isolated from the tail was used for 20µL 
PCR reaction. We used gene specific primers for CRT-HA, Cdh, and EGFP in the PCR 
mixture to examine the expression of CRT cDNA-HA tag coding sequence, Cadherin and 
EGFP respectively. The sequences for each primer are listed in (Table 3.7). The optimum 
annealing temperature was determined as being 60°C. The DNA was amplified by a single 
denaturing cycle for one minutes at 98°C followed by 40 amplification cycles as follows: 
98°C for 5 sec; 60°C for 5sec and 72°C for 20 sec. Each PCR reaction also contained a 
PCR positive control and negative control. PCR products were separated on a 1% agarose 
gel and visualized by ethidium bromide staining. Images were visualized using the Bio-
Rad Gel-Doc system. A fragment with the expected band size was amplified from the 
transgene and was only detected in samples from transgenic mice.  
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Figure 3.1 Schematic diagram showing the transgene used to generate ECCRT+ mice. 
The transgene cassette consists of the full-length CRT cDNA including the NH2-terminal 
signal sequence, CRT cDNA followed by the HA epitope tag and ending with the KDEL 
ER retrieval signal at the COOH-terminal. The transgene was under the control of the Tie2 
promoter and the Tie2 Enhancer. I would like to acknowledge Dr. Nasrin Mesaeli for 
designing, generating and establishing the mice colonies, genotyping and initial histo-
pathological analysis of the mice in her lab in Canada.  
  
CRT cDNA
KDEL-ER Retention Signal 
HA-Tag (Hemagglutinin Tag) 
Tie2 Promoter Tie2 Enhancer
5’ 3’
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3.2.5 Western blot analysis 
The expression of different proteins in wt and ECCRT+ were determined using 
western blot analysis. Briefly, tissues were collected from wt and ECCRT+ and washed in 
ice cold phosphate buffer saline (1XPBS). Lysis buffer was added to the collected tissues 
for homogenization. Tissue lysates were then centrifuged at 10,000 rcf for 10 mins at 4°C. 
Supernatants were collected and protein concentrations were measured using PierceTM 
BCA Protein Assay Kit (Thermo-scientific). A total of 40µg of the total protein for each 
sample was loaded on 10% SDS- polyacrylamide gel (SDS-PAGE). Protein standard 
Precision Plus-ProteinTM Dual Color Standard (Bio-Rad) was used as a reference molecular 
size of the proteins. The proteins were then transferred to nitrocellulose membrane using 
semi-dry transfer technique.  
To ensure that the proteins has been transferred completely, nitrocellulose 
membrane was stained with Ponceau S staining solution (Sigma) prepared in acetic acid. 
The nitrocellulose membrane was incubated in 5% non-fat skim milk powder prepared in 
1XPBS for 60 mins at room temperature to block non-specific binding. Then, the 
membrane was incubated with the primary anti-body diluted in 5% non-fat skim milk in 
1XPBS with continuous shaking for different time as required for each anti-body. The 
membrane was washed two times for 15 mins with 1XPBS containing 0.1% Tween and 
once with 1XPBS to remove unbinding unbound residues. The membrane was then 
incubated for one hour at room temperature with fluorescently tagged secondary anti-body 
prepared in 5% non-fat skim milk powder in 1XPBS with (1:15,000 dilution). The 
membrane was washed again for three times as above and visualized using Licor odyssey 
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CLX-Infrared (Imaging System). To ensure the equal loading of the protein samples, the 
same membrane was re-incubated with α-actin or Tubulin anti-body (sigma) repeating 
same conditions as described above.  
3.2.6 Examining the endothelial dysfunction 
3.2.6.1 Examining eNOS expression  
Western blot analysis was carried out with proteins isolated from wt and ECCRT+ 
whole mesenteric arteries using a rabbit anti-eNOS (NeoMarkers) to detect the expression 
of enzyme nitric oxide synthase (eNOS). Further details of the western blot analyses carried 
out in this study are explained in section 3.2.5.  
3.2.6.2 RNA extraction and quantitative real-time polymerase chain reaction (qRT-
PCR) analysis 
To examine changes in eNOS mRNA in the endothelium of the wt and ECCRT+ mice 
qRT-PCR was used. Total RNA was extracted using Trizol reagent and following 
manufacturer’s protocol. Briefly, mesenteric artery, descending aorta and fat from mice 
were collected in RNAase free tubes containing 1ml Trizol reagent. A total of 200µl of 
chloroform per 1ml of Trizol were added to the samples. Followed by centrifugation at 
13,000 rcf for 20 minutes at 4°C. Following the centrifugation, the mixture separates into 
three layers, lower red, phenol-chloroform phase, an interphase, and a colorless upper 
aqueous phase. The aqueous colorless phase where RNA remains in was transferred 
carefully without disturbing the interphase into fresh tube. Precipitating the RNA was done 
by adding 500µl isopropyl alcohol to the colorless liquid in the fresh tube. Then, mixing 
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and centrifugation was done at 4°C for one hour at 13,000 rcf. RNA will precipitate as 
small pellet on the tube side. The supernatant was removed and 750µl 75% of ethanol 
prepared in DEPC water were added to the samples. The samples were then centrifuged at 
4°C for 10 minutes at 7500 rcf, ethanol was completely removed, and RNA pellet were 
dried and then dissolved in DEPC water according to the pellet size.  
The cDNA was synthesized using cDNA synthesis kit (Invitrogen) following the 
manufacturer’s instructions. A total of 25ng of the cDNA was used for qRT-PCR in a Quat 
Studio 6Flex thermal cycler (Applied Biosystems) using SYBR green from Invitrogen. 
Briefly, a total of 5µl of cDNA in a final volume of 20µl reactions were carried out in 
MicroAmp1 Fast Optical 96-well plates (Thermo Fischer Scientific), under the following 
program: 20 min at 95 C, followed by 40 cycles of 3sec at 95°C and 30sec at 60°C, and a 
dissociation curve. Total of 250ng of gene specific primers was used to amplify eNOS and 
r18S (ribosomal RNA), the list of primers is provided in (Table 3.7).  eNOS target gene 
expression was normalized to an endogenous control (r18S) and the average Ct value from 
each triplicate was used to calculate fold induction of the gene in the ECCRT+ mice 
compared to the wt mice.  
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Table 3.7 LIST OF PRIMERS 
 
Items Forward  Reversed  
CRT-HA 
5’CTCATCACCAACGATG
AGG3’ 
5’CCTGTCTAGCATAGTCAG
G3’ 
PPARg2 
5’AAGAGCTGACCCAATG
GTTG3’ 
5’ACCCTTGCATCCTTCACA
AG3’ 
CEBPa 
5’CAAGAACAGCAACGA
GTACCG3’ 
5’GTCACTGGTCAACTCCAGC
AC3' 
ADIPOQ 
5’TGTTCCTCTTAATCCTG
CCCA3’ 
5’CCAACCTGCACAAGTTCC
CTT3’ 
r18S  
5’GTAACCCGTTGAACCC
CATT3’ 
5’CCATCCAATCGGTAGTAG
CG3’ 
eNOS 
5’TCAGCCATCACAGTGT
TCCC3’ 
5’ATAGCCCGCATAGCGTAT
CAG3’ 
Cdh 
5’CCAGGCTGACCAAGCT
GAG3’ 
5’CCTGGCGATCCCTGAACA
3’ 
EGFP 
5’TAGAGCTTGCGGAACC
CTTC3’ 
5’CTTTAAGCCTGCCCAGAA
GA3’ 
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3.2.7 Characterization of the wt and ECCRT+ 
3.2.7.1 Histological analysis 
3.2.7.1.1 Tissue preparation 
Adipose tissues were collected from the wt and ECCRT+ mice. The tissues were fixed 
in 4% paraformaldehyde (PFA) (paraformaldehyde, Prills, 95%-Sigma) for overnight and 
embedded in paraffin and processed using tissue processer machine (Fisher Tissue Path, 
Fisher Health care). Tissues were sectioned (5µm) using Microtome and mounted on 
Superfrost Plus slides (VWF, USA). The sections were placed on a heat block at 50°C 
overnight to adhere the section to the glass slide, then cooled at room temperature and 
stored until use.   
3.2.7.1.2 Hematoxylin and eosin staining  
Adipose tissue sections from each wt and ECCRT+ mice were stained using 
histological techniques to examine the phenotypic changes (shape and size) of adipocyte 
in these mice. Sections were stained with Hematoxylin and Eosin staining protocol of 
Harris Hematoxylin (Prophet et al. 1994). Briefly, sections were deparaffinized in xylene 
for 5 minutes followed by hydration process through serial incubation in 100, 95, and 70 
% ethanol for 1 minutes each. Slides were then washed with tap water then with distilled 
water for total hydration. Sections were then stained with hematoxylin staining for 30 
seconds (nuclear staining) and washed in running tap water for 1 minute followed by quick 
wash with distilled water and then differentiated in 1% acid alcohol (1% hydrochloric acid 
in 70% ethanol) for 30 seconds.  
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Slides were washed in running tap water for 1 minute and counterstained in eosin-
phloxine solution (quick – 7 dunks) for cytoplasmic staining. After staining, sections were 
washed and dehydrated through two changes of 95% alcohol and absolute alcohol for 2 
minutes for each, then cleared in xylene for 5 minutes twice. Coverslips were then mounted 
on slides with pre-mount mounting media (Electron microscopy science).  
3.2.7.1.3 Quantification of adipocyte size and numbers  
5-6 images were obtained from each section of adipose tissue isolated from the wt 
and ECCRT fed standard diet. Tissues were analyzed to quantify the size and number of 
adipocytes in each field using a Zeiss Axiovision microscope equipped with an AxioCam 
and analyzed with the Axiovision SE64 version 4.8 program. Adipocytes at the image 
borders were calculated as a number by drawing a line inside the adipocyte, but they were 
not counted for size quantification.  as shown in (Figure 3.2) 
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Figure 3.2 Quantification of the adipocyte size and number. By using Axiovision SE64 
software the quantification has been done by drawing on the adipocyte as shown in the 
figure which gave the size of the adipocyte and represent the numbers. Adipocytes at the 
figure borders were calculated as a number by drawing a line inside the adipocyte, but they 
were not counted for size quantification.   
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3.2.8 Diet experiment of the wt and ECCRT+ mice 
To examine the effect of diet on the phenotype of the wt and ECCRT+, 4 weeks old 
wt and ECCRT+ litter-mate mice were fed with special diet containing either high fat (60%) 
or regular fat (10%) diet for different length (8-24 weeks). 20 pellets of food which is equal 
to 20 grams of food per week was given to these mice. A total of 10 mice was included in 
each group. Body weight and blood glucose measurements using one touch ultra-soft 
machine were obtained for each mouse bi-weekly after fasting the mice for 6 hours. At the 
end time of study for each group, glucose tolerance test (GTT) were measured for each 
mouse (see details below). The next day after the GTT test, mice were euthanized; blood, 
epididymal fat, liver, descending aorta, kidney, heart, lungs, and skeletal muscle were 
collected. Fat tissues were sectioned and stained using histological techniques for 
quantification of the adipocytes size and number. Phenotypic characteristics that observed 
visually were also recorded. Serum was collected and used for metabolomics analysis by 
Metabolon LTD, USA.   
3.2.8.1 Glucose tolerance test (GTT)  
At the end time point, each mouse fed the high fat (60%) or regular fat (10%) diet 
was fasted for 16 hours then body weight was measured, and 2g glucose/kg body weight 
of sterilized glucose was injected intraperitoneally into the mice according to their body 
weight. Blood samples was collected every 30 minutes up to 2 hours to check the glucose 
level in mg/dl.   
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3.2.8.2 RNA extraction and quantitative real-time polymerase chain reaction (qRT-
PCR) analysis 
Fat tissues were isolated from the wt and ECCRT+ mice of different group (8w, 16w, 
and 24w) to examine the changes in gene expression of the most studied genes related to 
adipogensis (Adiponectin, PPARg, and CEBPa). Further details for RNA extraction and 
qRT-PCR analysis carried out in this study are explained in section 3.2.6.2.   
3.2.9 Angiogenesis in Cdh-ECCRT+-EGFP 
To examine changes in angiogenesis in the transgenic mice, heart, fat, descending 
aorta and mesenteric artery tissues were collected from the Cdh-ECCRT+-EGFP and Cdh-
EGFP mice and fixed in 4% PFA and then was proceed for histological sectioning as 
previously described in section [3.2.7.1.1 Tissue preparation]. Images were taken using a 
Zeiss Confocal microscope.  
3.2.10 Statistical analysis  
The data was analyzed using widely accepted statistical software (Prism). Unpaired 
student’s T-test was used for adipocyte quantification and ANOVA was used for GTT 
analysis. Significant difference was defined as P value<0.05. For qRT-PCR analysis, 
results were calculated using the DDCT and are expressed as the mean ±S.D. of three 
samples each assayed in duplicate.  
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CHAPTER 4. RESULT  
4.1 Genotyping confirmation of the wild-type and transgenic mice (wt, ECCRT+, and 
Cdh-ECCRT+ -EGFP) 
Mice were generated at WCM-Q by breeding, tail biopsies from these mice were 
used for genotyping, by PCR and western blot, to identify the transgenic mice 
overexpressing CRT under the control of Tie2 promotor (ECCRT) and the wt. Figure 4.1A 
shows a representative Western blot of the protein isolated from mouse tails blotted with 
anti-HA antibody. Figure 4.1B, shows a representative PCR image of the genomic DNA 
and specific primers of CRT C-terminus and HA tag (Table 3.7) demonstrating the desired 
band of CRT-HA amplification in the transgenic mice, ECCRT+, and absence of this band 
in the wt mice. Genotyping of Cdh-ECCRT+-EGFP and Cdh- EGFP was carried out as 
described in material and methods using specific primers to detect VE-Cadherin, CRT-HA 
and EGFP listed in (Table 3.7). Figure 4.2A, B, and C illustrates the results of a 
representative PCR using the three different primers to amplify the target sequence. CRT-
HA positive and negative, Cdh, and EGFP positive transgenic mice which were used for 
examining the angiogenesis differences between these mice.   
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A. 
 
 
 
B.  
 
 
 
 
 
 
Figure 4.1 Genotyping of ECCRT+ mice Transgenic mice using tail biopsies.  (A) A 
representative Western blot analysis using an anti-HA antibody and anti-actin as a loading 
control. A single protein band at 65 kDa was detected in the ECCRT samples only. (B) Using 
the genomic DNA isolated from tail biopsies and specific primers PCR was performed as 
described in Material and Methods. A representative gel shows the PCR product of 
genomic DNA of ECCRT mice and wt A 200 bp amplicon was detected in the samples from 
transgenic mice only (samples: 3-7,10, 12-17, 18, 19 are positive) (samples:1, 2, 8, 9, 11, 
20 are negative). Sample 21 represent the positive control and sample 22 represent the 
negative control where L is 1kb ladder. 
wt
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Figure 4.2 Genotyping of Cdh-ECCRT+ -EGFP and Cdh-EGFP by PCR analysis. PCR 
reaction of the genomic DNA from mouse litters were set to identify Cadherin, EGFP and 
CRT-HA. Samples in lane 1-8 were PCR of genomic DNA of transgenic mice lane 9 and 
10 are the positive control (a universal primer and gene specific primer respectively). A) 
A representative PCR for Cdh-cre, B) A representative PCR for EGFP primer. C) A 
representative PCR for CRT-HA primer.  
345bp 
128bp 
200bp 
1 2 3 4 5 6 7 8 9 10 11 
1 2 3 4 5 6 7 8 9 10 11 
1 2 3 4 5 6 7 8 9 10 11 
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4.2 Examining the presence of endothelial dysfunction in the transgenic mice ECCRT+ 
One of the objective of our study was to examine changes in endothelial function 
in the ECCRT+ mice. As mentioned earlier, preliminary data from our lab on the vascular 
function showed a significant decrease in mesenteric artery relaxation after administration 
of acetylcholine in the ECCRT+ mice compared to the wt mice. The defect in relaxation was 
overcome when applying a NO donor SNP. This observation suggested that the ECCRT+ 
mice suffer from endothelial dysfunction as a result in changes in NO production.  To 
examine the status of eNOS in the ECCRT+ mice, western and qRT-PCR was carried out. 
Figure 4.3, illustrates that eNOS protein expression is significantly reduced in ECCRT+ 
mesenteric arteries as compared to the wt mesenteric arteries. In the western blot HUVEC 
cell (human umbilical vein endothelial cells) lysates were used as a positive control because 
they are expressing eNOS. As shown in the Figure 4.3, eNOS is expressed in the HUVEC, 
wt and the ECCRT+ mesenteric arteries. However, in the transgenic mice, the expression of 
eNOS is significantly decreased.  
To determine whether changes observed in eNOS protein is due to gene expression 
or protein stability we carried out qRT-PCR of eNOS on RNA isolated from different 
arteries and adipose tissue from the wt and transgenic mice. Figures 4.4 summarizes the 
qRT-PCR results for the expression of eNOS gene on the isolated mesenteric artery, 
descending aorta and fat tissues from 4-5 different wt and ECCRT+ mice. As shown there 
was a significant reduction in eNOS mRNA in different tissues isolated from the ECCRT+ 
as compared to the wt. 
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Figure 4.3 eNOS expression of ECCRT+ and wt mice. Western blot analysis using an anti-
eNOS antibody and anti-tubulin as a loading control. (A) Proteins extracted from HUVEC 
cell line (endothelial cells) and mesenteric arteries isolated from the wt and ECCRT mice 
was resolved on a 7.5% SDS acrylamide gel. Lower panel is the same blot probed with 
antibody to Tubulin to assess equal loading of the samples. (B) eNOS protein 
quantification. Bar graphs are mean ± SE of n=3 mice in each group. ** P<0.01, as 
compared to the wt mice. 
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Figure 4.4 Quantification of qRT-PCR of eNOS in different tissues of wt and ECCRT+ 
mice. The qRT-PCR was carried on 4-5 separate RNA extractions. ΔΔCT was calculated 
to reference gene r18S for each sample. Bar graphs are mean ± SE of n=4-5 mice in each 
group. * P<0.05, ***P<0.001 as compared to the wt mice.   
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4.3 Characterization of adipose tissue in the ECCRT+ and wt mice 
One of the phenotypes that we observed while observing the ECCRT+ mice as they 
aged was increased amount of adipose tissue, specifically in the mesenteric region and 
associated with different internal organs and subcutaneous area, as compared to the wt 
mice. Therefore, we aimed to characterize the adipose tissue. The epididymal fat pad was 
isolated from different mice and fixed and prepared for histological analysis. As shown in 
Figure 4.5 hematoxylin and Eosin staining, there was a significant increase in the number 
of adipocytes in the fat pad of ECCRT+ as compared to the wt mice. Furthermore, we 
observed a significant reduction in the size of the adipocytes in the ECCRT+ as compared to 
the wt mice (Figure 4.5). The mice we examined in this experiment were fed a normal diet. 
This prompted us to expand our study and examine effect of normal fat diet (10%) and 
high fat diet (60%) on the adipocyte phenotype in these mice.  
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Figure 4.5 Characteristics of Adipocyte tissues.  Hematoxylin and Eosin staining of 
epididymal adipose tissue from ECCRT+ and wt mice on standard diet. 5-6 Image field from 
each specimen was analyzed to quantify the number and size of adipocytes in each field. 
Bar graphs showing the mean ± SE of 6 separate wt or ECCRT+ mice. *** P<0.001 as 
compared to the wt mice.  
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4.4 Characterization of metabolic phenotype in wt and ECCRT+ mice on different diet  
4.4.1 Body weight measurements  
To determine effect of increased fat intake on the phenotype of the ECCRT+ mice we 
fed the mice 10% or 60 fat diet for different time periods (8, 12, 16, 20 and 24 weeks). In 
this report I will highlight the changes in the 8, 16 and 24 weeks.  The body weight of wt 
and ECCRT+ mice fed for 8, 16 and 24 weeks were measured and recorded bi-weekly. At 
the end of time point the body weight was recorded and summarized in Figure 4.6. As seen 
in this figure, both the wt and ECCRT+ mice showed an increase in the body weight as the 
mice aged from week 8 to week 24 under 10% and 60% fat diet. Furthermore, both the wt 
and ECCRT+ mice body weight significantly increased after feeding mice 60% fat diet at 8 
and 24 weeks as compared to the 10% fat diet. Interestingly, at 16 weeks, only ECCRT+ mice 
showed a significant increase in body weight on 60% fat diet. 
4.4.2 Glucose tolerance test  
As part of metabolic phenotyping of the mice we measured changes in blood 
glucose of the mice at end of time of treatment (8, 16 and 24 weeks). At the end of each 
time point wt and ECCRT+ mice fed the high fat (60%) or regular fat (10%) diet was sat for 
GTT. As described in materials and methods, the measurement was taken every 30 minutes 
for two hours.  As shown in figure 4.7 there were some differences in glucose uptake in 
the ECCRT+ mice as compared to the wt fed 10% fat diet. The difference was significant at 
24 weeks of age. However, under high fat diet, the glucose failed to return to normal level 
at 2 hrs. in the ECCRT+ mice compared to the wt (Figure 4.7D). At 16 and 24 weeks GTT 
was significantly different between the ECCRT+ mice and the wt mice under 60% fat.  
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Figure 4.6 Body weight measurements of ECCRT+ and wt mice. Mice were fed a diet 
containing 10% or 60% fat for 8,16, and 24 weeks. At end of the treatment dates mice were 
weighed. Data were represented as bar graphs as mean ± SE of n=10 mice in each group. 
* P<0.05, ***P<0.001as compared to the 10% fat diet.  
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Figure 4.7 Glucose tolerance test of wt and ECCRT+ mice. Mice were fed a diet containing 
10% or 60% fat for 8,16, and 24 weeks. At end of the treatment dates mice were weighed 
and glucose tolerance test was performed as described in Materials and Methods. Values 
were plotted against time to show the difference between the wt and ECCRT+ mice. Data 
were represented as bar graphs as mean ± SE of n=10 mice in each group. * P<0.05, ** 
P<0.01, ***P<0.001 as compared to the wt mice. 
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4.4.3 Phenotype of adipose tissue in wt and transgenic mice fed different diet 
To determine effect of increased fat intake on the size and number of adipocytes of 
the wt and ECCRT+ mice, epididymal fat tissues were isolated from the ECCRT+ and wt mice 
fed normal fat (10% Fat) and high fat diet (60%) for 8, 16 and 24 weeks. As shown in 
figure 4.8A, the adipocyte size in ECCRT+ mice fed 10% fat diet for 8 weeks was 
significantly lower as compared to the wt adipocytes. Furthermore, the total number of 
adipocytes at 8 weeks were significantly increased in ECCRT+ as compared with the wt 
(Figure 4.8B). Similarly, ECCRT+ mice fed 10% diet for 16 weeks showed a significantly 
lower cell size as compared to the wt with no change in cell number (Figure 4.9A and B).  
Interestingly, mice fed 10% fat diet for 24 weeks showed a significantly higher adipocyte 
size (Figure 4.10A) with no change in the number of adipocytes (Figure 4.10B).  
Figure 4.11 shows that when the mice were fed high fat diet (60%) for 8 weeks 
there were no difference in the adipocyte size and number between the two-mouse strain 
(ECCRT+ and wt). Similar data was observed when mice were fed 60% fat diet for 16 weeks 
(Figure 4.12). However, after 24 weeks on 60% diet the adipocytes in the ECCRT+ mice 
were significantly smaller as compared to the wt (Figure 4.12A) and they were significantly 
higher in number as compared to the wt mice (Figure 4.12B). 
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Figure 4.8 Characteristics of Adipocyte tissues isolated from mice fed 10% fat diet 
for 8 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 10% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B) of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. ** P<0.01, significantly different from the wt mice. 
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Figure 4.9 Characteristics of Adipocyte tissues isolated from mice fed 10% fat diet 
for 16 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 10% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B) of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. No significant differences observed. 
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Figure 4.10 Characteristics of Adipocyte tissues isolated from mice fed 10% fat diet 
for 24 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 10% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B) of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. * P<0.05, significantly different from the wt mice.  
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Figure 4.11 Characteristics of Adipocyte tissues isolated from mice fed 60% fat diet 
for 8 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 60% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B)of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. No significant differences observed. 
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Figure 4.12 Characteristics of Adipocyte tissues isolated from mice fed 60% fat diet 
for 16 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 60% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B)of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. No significant differences observed. 
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Figure 4.13 Characteristics of Adipocyte tissues isolated from mice fed 60% fat diet 
for 24 weeks.  Hematoxylin and Eosin staining of adipose tissue from wt mice and ECCRT+ 
mice on 60% fat diet. 5-6 Image fields from each specimen was analyzed to quantify the 
size (A) and number (B)of adipocytes in each field. Bar graphs showing the mean ± SE of 
3 separate wt or ECCRT+ mice. * P<0.05, significantly different from the wt mice.  
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4.5 Adipocyte specific gene expression profile 
As shown above there was a significant change in the adipocyte phenotype of the 
wt and ECCRT+ epididymal fat fed different fat diet. Therefore, we examined changed in 
expression of some fat specific transcription factors, Adiponectin, PPARg, CEBPa. 
Figures (4.14, 4.15 and 4.16) summarizes the qRT-PCR results for the expression of the 
three tested genes in the epididymal fat isolated from wt and ECCRT+ mice fed 10% and 
60% fat diet for different times.  As shown in Figure 4.14 adiponectin expression was lower 
in ECCRT+ fed with 10% fat diet as compared to the wt at the 3 times tested (Figure 4.14 
A). Interestingly, feeding the mice with 60% diet reduced expression of adiponectin in both 
the wt and the ECCRT+ mice (Figure 4.14B). The variation in the standard error bar was due 
to the variation between the mice of the same group although they were showing the same 
trend of genes that is downregulated.   
Figure 4.15 shows changes in the expression of PPARg in the epididymal fat 
isolated from the wt and the ECCRT+ mice fed different diets. There was a significant 
decrease in PPARg expression in mice fed 10% fat diet for 8 and 16 weeks with no 
difference in the 24 weeks time point (Figure 4.15B). However, after high fat diet (60% 
fat) PPARg expression was reduced in the ECCRT+ mice at all the three-time points (Figure 
4.15B.  
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Figure 4.16 summarizes the qRT-PCR data for CEBPa expression in the 
epididymal fat isolated from the wt and the ECCRT+ mice fed different diets. 10% fat diet 
had no significant difference in CEBPa expression at different weeks between the wt and 
the ECCRT+ mice (Figure 4.16A). Interestingly, feeding mice a diet containing 60% fat 
significantly reduced the expression of CEBPa in the ECCRT+ mice as compared to the wt 
mice at 8 and 16 weeks (Figure 4.16 B). Furthermore, at 24 weeks feeding with 60% fat 
diet, we observed no significant change in the CEBPa expression (Figure 4.16B).    
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Figure 4.14 qRT-PCR of fat tissue of ECCRT+ and wt mice under 10% and 60% fat 
diet. The figure shows the mRNA level of ADIPONECTIN. Downregulation of the three 
genes was observed on the mice under both fat diet (10% or 60%). Bar graphs are mean ± 
SE of n=3-6 mice in each group. ** P<0.01, as compared to the wt mice.  
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Figure 4.15 qRT-PCR of fat tissue of ECCRT+ and wt mice under 10% and 60% fat 
diet. The figure shows the mRNA level of PPARg. Downregulation of the three genes was 
observed on the mice under both fat diet (10% or 60%). Bar graphs are mean ± SE of n=3-
6 mice in each group. * P<0.05, ***P<0.001, as compared to the wt mice.  
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Figure 4.16 qRT-PCR of fat tissue of ECCRT+ and wt mice under 10% and 60% fat 
diet. The figure shows the mRNA level of CEBPa. Downregulation of the three genes was 
observed on the mice under both fat diet (10% or 60%). Bar graphs are mean ± SE of n=3-
6 mice in each group. ** P<0.01, as compared to the wt mice. 
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4.6 Angiogenesis in Cdh-ECCRT+-EGFP 
As previously discussed, angiogenesis plays an important role in the expansion of 
adipocytes and onset of obesity. In our preliminary work we have observed changes in 
vascular density in different tissue. Therefore, one of the objective of the current study was 
to measure changes in angiogenesis as one of the factors contributing to obesity. To 
examine the changes in the angiogenesis between the transgenic and wt mice, we developed 
Cdh-ECCRT+-EGFP and Cdh-EGFP (wt) mice as described in Material and Methods. 
Cryosections of different tissues from both Cdh-ECCRT+-EGFP and Cdh-EGFP mice were 
prepared as described in the Material and Methods.  Slides were washed with PBS and 
mounted with mounting media containing DAPI satin and visualized directly using a Zeiss 
confocal microscope. The main laser line used for EGFP excitation was the argon laser at 
488nm. During imaging the gain and pinhole were set constant for all images. Figure 4.17, 
shows representative images of sections of descending aorta, heart, mesenteric artery and 
visceral fat obtained from 2-3 Cdh-ECCRT+-EGFP and Cdh-EGFP mice. As observed in 
this figure, all tissue sections from the Cdh-ECCRT+-EGFP had a significantly higher 
number of endothelial cells (EGFP fluorescent, arrowheads) in comparison with Cdh-GFP 
(Figure 4.17).  
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Figure 4.17 Angiogenesis analysis in Cdh-ECCRT+-EGFP. Representative images of 
vasculature of different tissues obtained from Cdh-ECCRT+-EGFP and Cdh-EGFP mice. 
Green corresponds to the endothelial cells tagged with EGFP, while blue correspond to the 
DAPI stain. Arrow pointing to the endothelium of the arteries. Arrowheads represents the 
endothelial cells in the capillaries. Images were taken using a Zeiss Confocal microscope.  
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CHAPTER 5. DISCUSSION 
Overweight or obesity has become a public health concern worldwide. Obesity is 
defined as the accumulation of an abnormal or excessive fat which leads to a major health 
risks. Among the gulf regions, Qatar ranked sixth in obesity prevalence globally according 
to the international association for the study of obesity (NHS, 2012). Obesity results from 
an imbalance between energy intake and energy output, which is mainly associated with 
the adipose tissue expansion. Recently, it has been shown that adipose tissue not only stores 
excess energy, but it is considered to be the largest endocrine organ in the human body that 
exerts it effects on several other vital organs. In adults, the predominant type of fat is the 
subcutaneous and visceral WAT, where excess calories are stored in adipocytes as 
triglyceride molecules. Thus, the imbalance in energy leads to alterations in glucose and 
lipid disposal as well as dysregulation of adipocytokine expression in WAT. Oxidative 
stress and inflammation have been shown to be present in obese adipose tissue and can 
cause insulin resistance and adipose tissue dysfunction (Manna & Jain, 2015) 
It has become well-established that maladaptive responses in the insulin resistant 
adipocyte can impact organelles such as the ER which is the principal site of protein 
synthesis and folding. ER is involved in several cellular functions in addition to protein 
synthesis including storage of Ca2+, lipid synthesis and modification. These functions of 
the ER are helped by several ER resident proteins, also known as chaperones. One of the 
chaperones that has been shown to have multiple different functions is CRT. It plays an 
important role in protein folding, Ca2+ homeostasis, cell adhesion and lipid/phospholipid 
synthesis (Chaudhari et al., 2014). 
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As part of the quality control in the ER, CRT binds to the newly synthesized 
proteins and support them for correct tertiary structure folding. Improper protein folding 
will lead to accumulation of misfolded proteins in the ER that can activate unfolded protein 
response and ER stress (Rao & Bredesen, 2004). Thus, alteration in CRT expression could 
result in several changes in the cells. As previously mentioned that CRT could play a role 
in vascular development (Mesaeli et al., 1999). Like in other tissues, vasculature of adipose 
tissue provide oxygen, growth factors, nutrients, and cytokines to the developing tissue at 
different stages of tissue development and maintenance. During early development of 
adipose tissues, the progenitor cells receive these factors through vascular supply that help 
them differentiate into pre-adipocytes. Vascular endothelial cells form the inner barrier of 
the vessel wall and it is responsible for maintaining the vascular vasodilation and 
constriction. Defect in the endothelial cell function has been shown to result as a 
consequence of different diseases such as obesity, diabetes and high blood pressure (Lobato 
et al., 2012) (Singhal, 2005). An increase or decrease in the generation of reactive oxygen 
species is one of the causes of endothelial dysfunction (Montezano & Touyz, 2012). The 
fluctuation in the balance of these factors in the endothelium has an influence in the 
adipocyte cells which is responsible for the storage of fat which causes an impairment of 
adipocytes and may lead to obesity (Jankovic et al., 2016). 
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Various studies discussed the importance of CRT, however its role in the 
development of endothelial dysfunction has not been fully discussed. Furthermore, many 
studies have focused on how obesity induces endothelial dysfunction but, very little 
information is available on the role of endothelial dysfunction in the onset of obesity and 
diabetes. Therefore, in this study we examined the role of CRT in endothelial dysfunction 
and in the process of adipogenesis leading to the development of obesity and diabetes.  
In our lab we have generated a mouse model that overexpressed CRT in the 
endothelial cells (ECCRT+ mice) under the control of Tie2 promoter and enhancer (Figure 
3.1), which is a commonly used promoter for endothelial cells. Genotyping of the mice 
showed that the gene is incorporated in the mouse genome and the proteins are expressed 
in the arterial wall from the transgenic mice (Figure 4.1). Overall, we have observed a 20-
25% increase in the CRT protein expression (Data not shown). One of the main phenotypic 
changes in these transgenic mice is the development of obesity and diabetes as they aged. 
The question which raise due to this observation was how overexpression of CRT in the 
endothelial cells can induce obesity? One of our initial postulate was that this could be 
mediated through onset of endothelial dysfunction. Indeed, De Boer et al. 2012 have 
reported that in obese people, impairment of endothelial function result in impair activation 
of endothelial nitric oxide synthase (eNOS) (De Boer et al., 2012). The reduction in eNOS 
reduces NO-dependent vasodilation and NO production (Hoier & Hellsten, 2014) (F. Kim 
et al., 2005) (Witting et al., 2007).  
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As shown in Figure 4.3 and 4.4, overexpression of CRT resulted in a significant 
reduction in eNOS expression at the level of protein and mRNA. Furthermore, previous 
preliminary research in our lab on the mesenteric artery function of ECCRT+ mice we 
observed a significant reduction in the relaxation of mesenteric artery in response to 
acetylcholine stimulation (Figure 2.3). These studies also showed that addition of NO 
donor (SNP) could recover the relaxation of the mesenteric artery of ECCRT+ mice (Figure 
2.4). Overall, these data suggest the onset of endothelial dysfunction upon overexpression 
of CRT in the endothelial cells. Based on the previous publication we suggest that 
endothelial dysfunction in the ECCRT+ mice plays an important role in the increased obesity 
in these mice. 
As mentioned above one of the phenotypic changes of ECCRT+ mice are the 
development of obesity and diabetes. The mice had a large volume of visceral and 
subcutaneous adipose tissue. Adipose tissues are the main depot for storing extra food 
intake as fat thus causing obesity. Development of adipose tissue is achieved through 
adipogensis process. Any alteration in this process could lead to obesity and many other 
diseases. A role for CRT in adipose cell development has been suggested (Szabo et al., 
2009) but limited information is available on the effect of CRT on adipose tissue and 
obesity in vivo. To examine the phenotype of adipose tissue in the ECCRT+ mice, we 
examined sections of epididymal fat isolated from the ECCRT+ mice and their wt littermates.  
Interestingly, we observed a significant increase in the cell number with a decrease in cell 
size in the ECCRT+ mice as compared to the wt mice. This suggest that in the ECCRT+ mice, 
there is adipocyte hyperplasia not hypertrophy. Increased cell number will contribute to the 
increase in obesity with over-feeding. Previous reports showed that when examining  
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different cellular pattern in terms of various aspect of body composition, body size, and 
age of onset of obesity, only the latter uniquely distinguishes the hyperplastic from the 
hypertrophic obesity (Murphy et al., 2017)(Salans et al., 1973). Interestingly, hyperplastic 
obesity was characterized by an early age of onset, and hypertrophic by a late age of onset 
(Murphy et al., 2017). How this could be correlated to our transgenic mouse model was of 
interest to us. Therefore, we examined the changes in the adipocytes challenged with 
different fat diet. Indeed, in our mouse model they had higher adipocyte number initially 
suggesting early hyperplasia, as the mice aged (fed high fat diet) the adipocytes undergone 
hypertrophy (as seen in (Figure 4.8-4.13). 
To characterize if CRT has an effect on the adipogenic process we fed 4 weeks old 
wt and transgenic (ECCRT+) litter mate mice with special diet containing either high fat 
(60%) or regular fat (10%) diet for different time points (8-24 weeks). To ensure that the 
mice had similar food intake (and eliminate the possibility that one mouse line were 
overfeeding), they were given the same amount of food, 20 pellets of food which is equal 
to 20 grams of food per week. At the end time point (8, 16 or 24 weeks) glucose tolerance 
test (GTT) was performed to determine the state of diabetes.  
 Epididymal adipose tissues were collected from the wt and ECCRT+ mice for 
histological analysis. As shown in (Figure 4.6) there were no significant change in total 
body weight between the ECCRT+ and wt mice fed 10% fat diet. Similarly, there was no 
difference between the two-mouse line after feeding 60% fat diet. This could be attributed 
to the fact that we ensured equal amount of food intake by the two mouse lines. Further 
analysis of the body weight we observed a 65% increase in body weight in wt mice fed 
60% fat diet while the ECCRT+ had increased by 94%, that is they gained more body weight 
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overall at 8 weeks. The same was also observed at 16 weeks (wt 75% and ECCRT+ had 98% 
increase) while at 24 weeks the percentage increase was reversed (wt 145% and ECCRT+ 
had 125% increase). Despite the observation of no changes in body weight between the 
two mouse lines under controlled feeding experiments, we recently received metabolomics 
data showing significant differences in several metabolites at each time point tested (data 
not shown, and currently being analyzed further).  
For phenotypic analysis of the adipose tissue, we carried out the quantification of 
adipocyte size and numbers. As shown in Figures 4.8 to 4.13 we observed changes in the 
adipocyte cell size and number. Similar to our data from mice on standard chow, at 8 weeks 
under 10% there was a higher number of adipocyte in ECCRT+ with a significantly smaller 
size (Figure 4.8). Interestingly, as the mice aged (16 and 24 weeks on 10% fat diet), the 
number of cells became equal between the two mouse lines (Figure 4.9 and 4.10). This 
observation suggests that the hyperplasia had perhaps started at the early development and 
then it was maintained as the mice grew older. Figure 4.9 also illustrates that the adipocytes 
were still smaller in the ECCRT+ mice at 16 weeks after 10% fat diet, however at 24 weeks 
this difference was lost. This illustrates that the adipocytes of ECCRT+ increase in size as 
the mice age.  After high fat diet feeding for only 8 weeks the size of the adipocyte in the 
ECCRT+ increased to the same as wt and interestingly there were no differences in the 
number of adipocytes (Figure 4.11). The same was observed for the 16 weeks. This suggest 
that on high fat diet there is increase in the size of adipocytes in both mice at 8 and 16 
weeks.  
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On the other hand, after 24 weeks on 60% fat diet the number of adipocytes 
increased in the ECCRT+ mice (Figure 4.13). While, the wt adipocytes increased in size upon 
60% fat diet for 24 weeks but the ECCRT+ adipocytes did not change in size (Figure 4.13). 
This suggest that possibly the ECCRT+ adipocytes have reached their maximum size. 
The association between obesity and diabetes is well established. Although, not all 
obese will become diabetic and vice versa. Our results illustrated that ECCRT+ mice fed 
60% Fat diet had more resistance to return their circulating blood glucose to normal at the 
end of GTT even at 8 weeks of age. This was even worse at 16 and 24 weeks (Figure 4.7).  
Interestingly, at 10% fat diet (regular diet) the ECCRT+ exhibited defect in ability to restore 
glucose level to normal after GTT test only at 24 weeks of feeding.  
There are a number of adipogenic transcription factors and adipokines which has 
been shown to play an important role in the adipogenesis and can be considered as marker 
for adipogenesis. The peroxisome proliferator activated receptor gamma 2 (PPARg2), 
CCAAT-enhancer binding protein a (CEBPa), and adiponectin are the most common 
adipogenic markers involved in adipose tissue development process (Miettinen et al., 
2008). A study conducted by Winrow et al. 2002 showed that CRT can act as a negative 
regulator of PPARg and it can also bind to GC-rich stem-loop structures causing inhibition 
of CEBPa mRNA translation (Winrow et al., 1995).   
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Szabo and colleagues showed that when CRT is overexpressed, PPARg is 
downregulated suggesting again that CRT modulate PPARg by a negative feedback 
mechanism (Szabo et al., 2009). Since PPARg is consider the master regulator of the 
adipogenesis process, aberrant expression of CRT may alter the function of PPARg 
therefore affect the adipogensis process. In this study, we showed that our ECCRT+ mice 
that overexpress CRT in endothelial cells express lower level the adipogenic markers 
PPARg, and Adiponectin when fed either 10 or 60% fat diet for the different time points 
(8,16, and 24 weeks) (Figure 4.14 and 4.15). The effect after high fat diet was more 
significant. CEBPa was not different in ECCRT+ mice as compared to wt mice fed 10% diet 
(Figure 4.16A).  However, it was significantly reduced upon feeding mice a 60% fat diet 
(Figure 4.16B). This suggest that the changes in the endothelial cells have an indirect effect 
on the adipocytes. Lemoine et al. 2013 suggested that the level of expression of several 
adipokines including Adiponectin are either positively or negatively correlated with the 
adipose area (Lemoine et al., 2013). This study supports our observation of decreased 
Adiponectin expression in the ECCRT+ mice under 10% fat diet and smaller size of the 
adipocyte. However, under high fat diet the increased intake of calories perhaps masked 
the effect of lower Adiponectin expression and the cell size was back in to different from 
the wt mice. 
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Finally, one of our hypothesis early in our study was a possible effect of changes 
in angiogenesis in the ECCRT+ mice as a mean to alter adipogenesis. Adipose tissue is a 
highly vascularized tissue and each adipocyte is surrounded by an extensive capillary 
network which is essential for its expansion (Lemoine et al., 2013) (Lijnen, 2008). Previous 
reports have showed a correlation between angiogenesis and increased adipogenesis 
(Lemoine et al., 2013) (Lijnen, 2008). In the current study we examined whether CRT has 
an effect on angiogenesis in vivo, using the Cdh- ECCRT+-EGFP mice which express EGFP 
and overexpress CRT in the endothelial cells. Our data showed that indeed, ECCRT+ has a 
higher number of capillaries in different tissues including fat (Figure 4.17) as compared to 
the wt mice. Our result from fat, mesenteric artery and heart sections from Cdh- ECCRT+-
EGFP mice showed a significant increase in the capillaries as compared to Cdh-EGFP 
mice. The increase in the capillary number suggests activation of the angiogenesis process 
could be due to overexpression of CRT. In this mouse model increase in CRT and increase 
in angiogenesis has a very early onset (before birth). To date we do not know the time of 
onset of endothelial dysfunction. Our experiments to assess endothelial dysfunction were 
carried out on 8 weeks or older mice. It will be interesting to examine changes in 
endothelial function at the embryonic stage. This is one of the future line of investigation 
using our mouse model. Further experiments are required to confirm the correlation 
between the increased angiogenesis process to adipogenesis in our transgenic mouse 
model, however, this initial data showed a possible association between these two 
processes.  
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FUTURE DIRECTION:  
1. Understand the changes in the metabolic profile of our generated transgenic and wt 
mice from the mice under diet experiment.  
2. Measuring the eNOS expression level from the tissues and endothelial cells of the 
Cdh- ECCRT+ -EGFP- mice.  
3. Increasing the number of the mice from the diet feeding experiment for 
quantification of adipocyte size and numbers.   
LIMITATION:  
Due to the limited time of the thesis submission, we were not able to finish the analysis 
of adipocyte phenotype in all of the mice. Thus, we were not able to complete the 
statistical analysis. 
 
 
 
 
 
 
  
   
 81 
References  
Achard, C. S., & Laybutt, D. R. (2012). Lipid-induced endoplasmic reticulum stress in 
liver cells results in two distinct outcomes: Adaptation with enhanced insulin 
signaling or insulin resistance. Endocrinology, 153(5), 2164–2177. 
https://doi.org/10.1210/en.2011-1881 
Adya, R., Tan, B. K., & Randeva, H. S. (2015). Differential effects of leptin and 
adiponectin in endothelial angiogenesis. Journal of Diabetes Research, 2015. 
https://doi.org/10.1155/2015/648239 
Avogaro, A., & De Kreutzenberg, S. V. (2005). Mechanisms of endothelial dysfunction 
in obesity. Clinica Chimica Acta. https://doi.org/10.1016/j.cccn.2005.04.020 
Baksh, S., & Michalak, M. (1991). Expression of calreticulin in Escherichia coli and 
identification of its Ca2+ binding domains. Journal of Biological Chemistry, 
266(32), 21458–21465. 
Basseri, S., Lhoták, Š., Sharma, A. M., & Austin, R. C. (2009). The chemical chaperone 
4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response. 
Journal of Lipid Research, 50(12), 2486–2501. https://doi.org/10.1194/jlr.M900216-
JLR200 
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000a). The versatility and universality of 
calcium signalling. Nature Reviews Molecular Cell Biology, 1(1), 11–21. 
https://doi.org/10.1038/35036035 
  
   
 82 
Berridge, M. J., Lipp, P., & Bootman, M. D. (2000b). The versatility and universality of 
calcium signalling. Nature Reviews. Molecular Cell Biology, 1(1), 11–21. 
https://doi.org/10.1038/35036035 
Boden, G. (2009). Endoplasmic reticulum stress: Another link between obesity and 
insulin resistance/inflammation? Diabetes. https://doi.org/10.2337/db08-1746 
Boden, G., & Merali, S. (2011). Measurement of the increase in endoplasmic reticulum 
stress-related proteins and genes in adipose tissue of obese, insulin-resistant 
individuals. Methods in Enzymology, 489(C), 67–82. https://doi.org/10.1016/B978-
0-12-385116-1.00004-2 
Bruemmer, D. (2012). Targeting angiogenesis as treatment for obesity. Arteriosclerosis, 
Thrombosis, and Vascular Biology, 32(2), 161–162. 
https://doi.org/10.1161/ATVBAHA.111.241992 
Bueter, W., Dammann, O., & Leviton, A. (2009). Endoplasmic reticulum stress, 
inflammation, and perinatal brain damage. Pediatric Research, 66(5), 487–94. 
https://doi.org/10.1203/PDR.0b013e3181baa083 
Caballero, A. E. (2003). Endothelial Dysfunction in Obesity and Insulin Resistance: A 
Road to Diabetes and Heart Disease. Obesity Research, 11(11), 1278–1289. 
https://doi.org/10.1038/oby.2003.174 
 
  
   
 83 
Cao, R., Brakenhielm, E., Wahlestedt, C., Thyberg, J., & Cao, Y. (2001). Leptin induces 
vascular permeability and synergistically stimulates angiogenesis with FGF-2 and 
VEGF. Proceedings of the National Academy of Sciences of the United States of 
America, 98(11), 6390–5. https://doi.org/10.1073/pnas.101564798 
Cao, Y. (2013). Angiogenesis and vascular functions in modulation of obesity, adipose 
metabolism, and insulin sensitivity. Cell Metabolism, 18(4), 478–489. 
https://doi.org/10.1016/j.cmet.2013.08.008 
Caramelo, J. J., Castro, O. A., Alonso, L. G., de Prat-Gay, G., & Parodi, A. J. (2003). 
UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent 
accessible hydrophobic patches in molten globule-like folding intermediates. 
Proceedings of the National Academy of Sciences, 100(1), 86–91. 
https://doi.org/10.1073/pnas.262661199 
Caramelo, J. J., Castro, O. A., De Prat-Gay, G., & Parodi, A. J. (2004). The endoplasmic 
reticulum glucosyltransferase recognizes nearly native glycoprotein folding 
intermediates. Journal of Biological Chemistry, 279(44), 46280–46285. 
https://doi.org/10.1074/jbc.M408404200 
Carpio, M. A., López Sambrooks, C., Durand, E. S., & Hallak, M. E. (2010). The 
arginylation-dependent association of calreticulin with stress granules is regulated 
by calcium. Biochemical Journal, 429(1), 63–72. 
https://doi.org/10.1042/BJ20091953 
  
   
 84 
Caruso, C., Balistreri, C. R., & Candore, G. (2010). The role of adipose tissue and 
adipokines in obesity-related inflammatory diseases. Mediators of Inflammation, 
2010. https://doi.org/10.1155/2010/802078 
Chan, R. S. M., & Woo, J. (2010). Prevention of overweight and obesity: How effective 
is the current public health approach. International Journal of Environmental 
Research and Public Health, 7(3), 765–783. https://doi.org/10.3390/ijerph7030765 
Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre dâ€TMHellencourt, C., & Ravanan, 
P. (2014). A Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and 
Oxidative Stress. Frontiers in Cellular Neuroscience, 8. 
https://doi.org/10.3389/fncel.2014.00213 
Chen, Y., Wu, Z., Zhao, S., & Xiang, R. (2016). Chemical chaperones reduce ER stress 
and adipose tissue inflammation in high fat diet-induced mouse model of obesity. 
Scientific Reports, 6. https://doi.org/10.1038/srep27486 
Corvera, S., & Gealekman, O. (2014). Adipose tissue angiogenesis: Impact on obesity 
and type-2 diabetes. Biochimica et Biophysica Acta - Molecular Basis of Disease. 
https://doi.org/10.1016/j.bbadis.2013.06.003 
De Boer, M. P., Meijer, R. I., Wijnstok, N. J., Jonk, A. M., Houben, A. J., Stehouwer, C. 
D., … Serné, E. H. (2012). Microvascular Dysfunction: A Potential Mechanism in 
the Pathogenesis of Obesity-associated Insulin Resistance and Hypertension. 
Microcirculation. https://doi.org/10.1111/j.1549-8719.2011.00130.x 
  
   
 85 
Decca, M. B., Carpio, M. A., Bosc, C., Galiano, M. R., Job, D., Andrieux, A., & Hallak, 
M. E. (2007). Post-translational arginylation of calreticulin: A new isospecies of 
calreticulin component of stress granules. Journal of Biological Chemistry, 282(11), 
8237–8245. https://doi.org/10.1074/jbc.M608559200 
Dedhar, S. (1994). Novel functions for calreticulin: Interaction with integrins and 
modulation of gene expression? Trends in Biochemical Sciences. 
https://doi.org/10.1016/0968-0004(94)90001-9 
Denzel, A., Molinari, M., Trigueros, C., Martin, J. E., Velmurgan, S., Brown, S., … 
Owen, M. J. (2002). Early postnatal death and motor disorders in mice congenitally 
deficient in calnexin expression. Molecular and Cellular Biology, 22(21), 7398–
7404. https://doi.org/10.1128/MCB.22.21.7398-7404.2002 
Dupuis, B. M., Schaerer, E., Krause, K., & Tschopp, J. (1993). The Calcium-binding 
Protein Calreticulin Is a Major Constituent of Lytic Granules in Cytolytic T 
Lymphocytes. Journal of Experimental Medicine, 177(January), 1–7. 
https://doi.org/10.1084/jem.177.1.1 
Farnier, C., Krief, S., Blache, M., Diot-Dupuy, F., Mory, G., Ferre, P., & Bazin, R. 
(2003). Adipocyte functions are modulated by cell size change: potential 
involvement of an integrin/ERK signalling pathway. International Journal of 
Obesity, 27(10), 1178–1186. https://doi.org/10.1038/sj.ijo.0802399 
 
  
   
 86 
Frickel, E.-M., Riek, R., Jelesarov, I., Helenius, A., Wuthrich, K., & Ellgaard, L. (2002). 
TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-
domain. Proceedings of the National Academy of Sciences, 99(4), 1954–1959. 
https://doi.org/10.1073/pnas.042699099 
Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., … Hotamisligil, G. S. (2011). 
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic 
reticulum stress in obesity. Nature, 473(7348), 528–531. 
https://doi.org/10.1038/nature09968 
Garg, A. (2011). Lipodystrophies: Genetic and acquired body fat disorders. Journal of 
Clinical Endocrinology and Metabolism. https://doi.org/10.1210/jc.2011-1159 
Giraldo, A. M. V., Medus, M. L., Lebrero, M. G., Pagano, R. S., Labriola, C. A., 
Landolfo, L., … Caramelo, J. J. (2010). The structure of calreticulin C-terminal 
domain is modulated by physiological variations of calcium concentration. Journal 
of Biological Chemistry, 285(7), 4544–4553. 
https://doi.org/10.1074/jbc.M109.034512 
Gold, L. I., Eggleton, P., Sweetwyne, M. T., Van Duyn, L. B., Greives, M. R., Naylor, S.-
M., … Murphy-Ullrich, J. E. (2010). Calreticulin: non-endoplasmic reticulum 
functions in physiology and disease. The FASEB Journal, 24(3), 665–683. 
https://doi.org/10.1096/fj.09-145482 
 
  
   
 87 
Gregoire, F. M., Smas, C. M., & Sul, H. S. (1998). Understanding adipocyte 
differentiation. Physiological Reviews, 78(3), 783–809. 
https://doi.org/10.1074/jbc.272.8.5128 
Gregor, M. F., & Hotamisligil, G. S. (2007a). Adipocyte stress: the endoplasmic 
reticulum and metabolic disease. Journal of Lipid Research, 48(9), 1905–1914. 
https://doi.org/10.1194/jlr.R700007-JLR200 
Gregor, M. F., & Hotamisligil, G. S. (2007b). Thematic review series: Adipocyte 
Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. 
Journal of Lipid Research, 48, 1905–1914. https://doi.org/10.1194/jlr.R700007-
JLR200 
Hammond, C., Braakman, I., & Helenius, A. (1994). Role of N-linked oligosaccharide 
recognition, glucose trimming, and calnexin in glycoprotein folding and quality 
control. Proceedings of the National Academy of Sciences, 91(3), 913–917. 
https://doi.org/10.1073/pnas.91.3.913 
Han, S., Sun, H. M., Hwang, K.-C., & Kim, S.-W. (2015). Adipose-Derived Stromal 
Vascular Fraction Cells: Update on Clinical Utility and Efficacy. Critical Reviews in 
Eukaryotic Gene Expression, 25(2), 145–52. 
https://doi.org/10.1615/CritRevEukaryotGeneExpr.2015013057 
 
 
  
   
 88 
Hebert, D. N., & Molinari, M. (2007). In and Out of the ER: Protein Folding, Quality 
Control, Degradation, and Related Human Diseases. Physiological Reviews, 87(4), 
1377–1408. https://doi.org/10.1152/physrev.00050.2006 
Helenius, A. (2001). Intracellular Functions of N-Linked Glycans. Science, 291(5512), 
2364–2369. https://doi.org/10.1126/science.291.5512.2364 
Hoier, B., & Hellsten, Y. (2014). Exercise-induced capillary growth in human skeletal 
muscle and the dynamics of VEGF. Microcirculation. 
https://doi.org/10.1111/micc.12117 
Ihara, Y., Kageyama, K., & Kondo, T. (2005). Overexpression of calreticulin sensitizes 
SERCA2a to oxidative stress. Biochemical and Biophysical Research 
Communications, 329(4), 1343–1349. https://doi.org/10.1016/j.bbrc.2005.02.112 
Jankovic, A., Korac, A., Buzadzic, B., Stancic, A., Otasevic, V., Ferdinandy, P., … 
Korac, B. (2016). Targeting the nitric oxide/superoxide ratio in adipose tissue: 
relevance in obesity and diabetes management. British Journal of Pharmacology, 
174, 1570–1590. https://doi.org/10.1111/bph.13498 
Jeffery, E., Peters, L. R., & Raghavan, M. (2011). The polypeptide binding conformation 
of calreticulin facilitates its cell-surface expression under conditions of endoplasmic 
reticulum stress. Journal of Biological Chemistry, 286(4), 2402–2415. 
https://doi.org/10.1074/jbc.M110.180877 
 
  
   
 89 
Jiang, Y., Dey, S., & Matsunami, H. (2014). Calreticulin: Roles in cell-surface protein 
expression. Membranes, 4(3), 630–641. https://doi.org/10.3390/membranes4030630 
Jo, J., Gavrilova, O., Pack, S., Jou, W., Mullen, S., Sumner, A. E., … Periwal, V. (2009). 
Hypertrophy and/or hyperplasia: Dynamics of adipose tissue growth. PLoS 
Computational Biology, 5(3). https://doi.org/10.1371/journal.pcbi.1000324 
Jorgensen, C. S., Trandum, C., Larsen, N., Ryder, L. R., Gajhede, M., Skov, L. K., … 
Houen, G. (2005). Conformational stability of calreticulin. Protein Pept Lett, 12(7), 
687–693. https://doi.org/10.2174/0929866054696082 
Kapoor, M., Srinivas, H., Kandiah, E., Gemma, E., Ellgaard, L., Oscarson, S., … Surolia, 
A. (2003). Interactions of substrate with calreticulin, an endoplasmic reticulum 
chaperone. Journal of Biological Chemistry, 278(8), 6194–6200. 
https://doi.org/10.1074/jbc.M209132200 
Katz,  a J., Llull, R., Hedrick, M. H., & Futrell, J. W. (1999). Emerging approaches to the 
tissue engineering of fat. Clinics in Plastic Surgery. 
Keller, S. H., Lindstrom, J., & Taylor, P. (1998). Inhibition of glucose trimming with 
castanospermine reduces calnexin association and promotes proteasome degradation 
of the ??-subunit of the nicotinic acetylcholine receptor. Journal of Biological 
Chemistry, 273(27), 17064–17072. https://doi.org/10.1074/jbc.273.27.17064 
 
  
   
 90 
Kim, F., Tysseling, K. a, Rice, J., Pham, M., Haji, L., Gallis, B. M., … Raines, E. W. 
(2005). Free fatty acid impairment of nitric oxide production in endothelial cells is 
mediated by IKKbeta. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(5), 
989–94. https://doi.org/10.1161/01.ATV.0000160549.60980.a8 
Kim, J. A., Montagnani, M., Kwang, K. K., & Quon, M. J. (2006). Reciprocal 
relationships between insulin resistance and endothelial dysfunction: Molecular and 
pathophysiological mechanisms. Circulation. 
https://doi.org/10.1161/CIRCULATIONAHA.105.563213 
Kolluru, G. K., Bir, S. C., & Kevil, C. G. (2012). Endothelial dysfunction and diabetes: 
Effects on angiogenesis, vascular remodeling, and wound healing. International 
Journal of Vascular Medicine, 2012(Figure 1). https://doi.org/10.1155/2012/918267 
Konieczny, S. F., & Emerson, C. P. (1984). 5-azacytidine induction of stable mesodermal 
stem cell lineages from 10T1/2 cells: Evidence for regulatory genes controlling 
determination. Cell, 38(3), 791–800. https://doi.org/10.1016/0092-8674(84)90274-5 
Kraus, A., Groenendyk, J., Bedard, K., Baldwin, T. A., Krause, K. H., Dubois-Dauphin, 
M., … Michalak, M. (2010). Calnexin deficiency leads to dysmyelination. Journal 
of Biological Chemistry, 285(24), 18928–18938. 
https://doi.org/10.1074/jbc.M110.107201 
 
 
  
   
 91 
Leach, M. R., Cohen-Doyle, M. F., Thomas, D. Y., & Williams, D. B. (2002). 
Localization of the lectin, ERp57 binding, and polypeptide binding sites of calnexin 
and calreticulin. Journal of Biological Chemistry, 277(33), 29686–29697. 
https://doi.org/10.1074/jbc.M202405200 
Lemoine, A. Y., Ledoux, S., & Larger, E. (2013). Adipose tissue angiogenesis in obesity. 
Thrombosis and Haemostasis, 110(4), 661–669. https://doi.org/10.1160/TH13-01-
0073 
Lijnen, H. R. (2008). Angiogenesis and obesity. Cardiovascular Research, 78(2), 286–
293. https://doi.org/10.1093/cvr/cvm007 
Lobato, N. S., Filgueira, F. P., Akamine, E. H., Tostes, R. C., Carvalho, M. H. C., & 
Fortes, Z. B. (2012). Mechanisms of endothelial dysfunction in obesity-associated 
hypertension. Brazilian Journal of Medical and Biological Research, 45(5), 392–
400. https://doi.org/10.1590/S0100-879X2012007500058 
Mandrup, S., Loftus, T. M., MacDougald, O. A., Kuhajda, F. P., & Lane, M. D. (1997). 
Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-
F442A preadipocytes. Proceedings of the National Academy of Sciences of the 
United States of America, 94(9), 4300–4305. https://doi.org/10.1073/pnas.94.9.4300 
 
 
  
   
 92 
Manna, P., & Jain, S. K. (2015). Obesity, Oxidative Stress, Adipose Tissue Dysfunction, 
and the Associated Health Risks: Causes and Therapeutic Strategies. Metabolic 
Syndrome and Related Disorders, 13(10), 423–444. 
https://doi.org/10.1089/met.2015.0095 
McCauliffe, D. P., Yang, Y. S., Wilson, J., Sontheimer, R. D., & Capra, J. D. (1992). The 
5’-flanking region of the human calreticulin gene shares homology with the human 
GRP78, GRP94, and protein disulfide isomerase promoters. Journal of Biological 
Chemistry, 267(4), 2557–2562. 
Mery, L., Mesaeli, N., Michalak, M., Opas, M., Lew, D. P., & Krause, K. H. (1996). 
Overexpression of calreticulin increases intracellular Ca2+ storage and decreases 
store-operated Ca2+ influx. Journal of Biological Chemistry, 271(16), 9332–9339. 
https://doi.org/10.1074/jbc.271.16.9332 
Mesaeli, N., Nakamura, K., Zvaritch, E., Dickie, P., Dziak, E., Krause, K. H., … 
Michalak, M. (1999). Calreticulin is essential for cardiac development. Journal of 
Cell Biology, 144(5), 857–868. https://doi.org/10.1083/jcb.144.5.857 
Michalak, M., Corbett, E. F., Mesaeli, N., Nakamura, K., & Opas, M. (1999). 
Calreticulin: one protein, one gene, many functions. The Biochemical Journal, 344 
Pt 2, 281–92. https://doi.org/10.1042/BJ3440281 
 
 
  
   
 93 
Michalak, M., Groenendyk, J., Szabo, E., Gold, L. I., & Opas, M. (2009). Calreticulin, a 
multi-process calcium-buffering chaperone of the endoplasmic reticulum. 
Biochemical Journal, 417(3), 651–666. https://doi.org/10.1042/BJ20081847 
Michalak, M., Parker, J. M. R., & Opas, M. (2002). Ca2+ signaling and calcium binding 
chaperones of the endoplasmic reticulum. Cell Calcium. 
https://doi.org/10.1016/S0143416002001884 
Miettinen, S., Sarkanen, J. R., & Ashammakhi, N. (2008a). Adipose Tissue and 
Adipocyte. Topics in Tissue Engineering, 4, 1–26. 
Miettinen, S., Sarkanen, J. R., & Ashammakhi, N. (2008b). Adipose Tissue and 
Adipocyte Differentiation: Molecular and Cellular Aspects and Tissue Engineering 
Applications. Topics in Tissue Engineering, 4, 1–26. 
Molinari, M., Eriksson, K. K., Calanca, V., Galli, C., Cresswell, P., Michalak, M., & 
Helenius, A. (2004). Contrasting Functions of Calreticulin and Calnexin in 
Glycoprotein Folding and ER Quality Control. Molecular Cell, 13(1), 125–135. 
https://doi.org/10.1016/S1097-2765(03)00494-5 
Montagnani, M., Ravichandran, L. V, Chen, H., Esposito, D. L., & Quon, M. J. (2002). 
Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required 
for insulin-stimulated production of nitric oxide in endothelial cells. Molecular 
Endocrinology (Baltimore, Md.), 16(8), 1931–42. https://doi.org/10.1210/me.2002-
0074 
  
   
 94 
Montezano, A. C., & Touyz, R. M. (2012). Reactive oxygen species and endothelial 
function--role of nitric oxide synthase uncoupling and Nox family nicotinamide 
adenine dinucleotide phosphate oxidases. Basic & Clinical Pharmacology & 
Toxicology, 110(1), 87–94. https://doi.org/10.1111/j.1742-7843.2011.00785.x 
Murphy, J., Moullec, G., & Santosa, S. (2017). Factors associated with adipocyte size 
reduction after weight loss interventions for overweight and obesity: a systematic 
review and meta-regression. Metabolism, 67, 31–40. 
https://doi.org/10.1016/j.metabol.2016.09.009 
Neels, J. G., Thinnes, T., & Loskutoff, D. J. (2004). Angiogenesis in an in vivo model of 
adipose tissue development. FASEB Journal : Official Publication of the Federation 
of American Societies for Experimental Biology, 18(9), 983–5. 
https://doi.org/10.1096/fj.03-1101fje 
NHS. (2012). Qatar Health Report 2012, 1–34. Retrieved from 
http://www.nhsq.info/app/media/1479 
Oliver, J. D., Van Der Wal, F. J., Bulleid, N. J., & High, S. (1997). Interaction of the 
thiol-dependent reductase ERp57 with nascent glycoproteins. Science, 275(5296), 
86–88. https://doi.org/10.1126/science.275.5296.86 
Onat, D., Brillon, D., AM, S., & PC, C. (2012). Human Vascular Endothelial Cells: A 
Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis. 
Curr Diab Rep, 11(3), 193–202. https://doi.org/10.1007/s11892-011-0182-2.Human 
  
   
 95 
Opas, M., Szewczenko-Pawlikowski, M., Jass, G. K., Mesaeli, N., & Michalak, M. 
(1996). Calreticulin modulates cell adhesiveness via regulation of vinculin 
expression. Journal of Cell Biology, 135(6 II), 1913–1923. 
https://doi.org/10.1083/jcb.135.6.1913 
Ostwald, T. J., & MacLennan, D. H. (1974). Isolation of a High Affinity Calcium-
binding Protein from Sarcoplasmic Reticulum. Journal of Biological Chemistry , 
249(3), 974–979. Retrieved from http://www.jbc.org/content/249/3/974.abstract 
Ozcan, L., & Tabas, I. (2012). Role of Endoplasmic Reticulum Stress in Metabolic 
Disease and Other Disorders. Annual Review of Medicine, 63(1), 317–328. 
https://doi.org/10.1146/annurev-med-043010-144749 
Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Ozdelen, E., … 
Hotamisligil, G. S. (2004). Endoplasmic reticulum stress links obesity, insulin 
action, and type 2 diabetes. Science (New York, N.Y.), 306(5695), 457–461. 
https://doi.org/10.1126/science.1103160 
Peters, L. R., & Raghavan, M. (2011). Endoplasmic Reticulum Calcium Depletion 
Impacts Chaperone Secretion, Innate Immunity, and Phagocytic Uptake of Cells. 
The Journal of Immunology, 187(2), 919–931. 
https://doi.org/10.4049/jimmunol.1100690 
 
 
  
   
 96 
Peterson, J. R., Ora, A., Van, P. N., & Helenius, A. (1995). Transient, lectin-like 
association of calreticulin with folding intermediates of cellular and viral 
glycoproteins. Molecular Biology of the Cell, 6(9), 1173–84. 
https://doi.org/10.1091/mbc.6.9.1173 
Pipe, S. W., Morris, J. A., Shah, J., & Kaufman, R. J. (1998). Differential interaction of 
coagulation factor VIII and factor V with protein chaperones calnexin and 
calreticulin. Journal of Biological Chemistry, 273(14), 8537–8544. 
https://doi.org/10.1074/jbc.273.14.8537 
Potenza, M. A., Marasciulo, F. L., Chieppa, D. M., Brigiani, G. S., Formoso, G., Quon, 
M. J., & Montagnani, M. (2005). Insulin resistance in spontaneously hypertensive 
rats is associated with endothelial dysfunction characterized by imbalance between 
NO and ET-1 production. American Journal of Physiology. Heart and Circulatory 
Physiology, 289(2), H813-22. https://doi.org/10.1152/ajpheart.00092.2005 
Prattes, S., Hörl, G., Hammer, A., Blaschitz, A., Graier, W. F., Sattler, W., … Steyrer, E. 
(2000). Intracellular distribution and mobilization of unesterified cholesterol in 
adipocytes: triglyceride droplets are surrounded by cholesterol-rich ER-like surface 
layer structures. Journal of Cell Science, 113 ( Pt 1, 2977–2989. 
Prieto, D., Contreras, C., & Sánchez, A. (2014). Endothelial dysfunction, obesity and 
insulin resistance. Current Vascular Pharmacology, 12(3), 412–26. 
https://doi.org/10.2174/1570161112666140423221008 
  
   
 97 
Rao, R. V., & Bredesen, D. E. (2004). Misfolded proteins, endoplasmic reticulum stress 
and neurodegeneration. Current Opinion in Cell Biology. 
https://doi.org/10.1016/j.ceb.2004.09.012 
Roderick, H. L., Lechleiter, J. D., & Camacho, P. (2000). Cytosolic phosphorylation of 
calnexin controls intracellular Ca2+ oscillations via an interaction with SERCA2b. 
Journal of Cell Biology, 149(6), 1235–1247. https://doi.org/10.1083/jcb.149.6.1235 
Rooke, K., Briquet-Laugier, V., Xia, Y. R., Lusis, A. J., & Doolittle, M. H. (1997). 
Mapping of the gene for calreticulin (Calr) to mouse chromosome 8. Mammalian 
Genome, 8(11), 870–871. https://doi.org/10.1007/s003359900599 
Rupnick, M. A., Panigrahy, D., Zhang, C.-Y., Dallabrida, S. M., Lowell, B. B., Langer, 
R., & Folkman, M. J. (2002). Adipose tissue mass can be regulated through the 
vasculature. Proceedings of the National Academy of Sciences, 99(16), 10730–
10735. https://doi.org/10.1073/pnas.162349799 
Salans, L. B., Cushman, S. W., & Weismann, R. E. (1973). Studies of human adipose 
tissue. Adipose cell size and number in nonobese and obese patients. The Journal of 
Clinical Investigation, 52(4), 929–941. https://doi.org/10.1172/JCI107258 
Sambrooks, C. L., Carpio, M. A., & Hallak, M. E. (2012). Arginylated calreticulin at 
plasma membrane increases susceptibility of cells to apoptosis. Journal of 
Biological Chemistry, 287(26), 22043–22054. 
https://doi.org/10.1074/jbc.M111.338335 
  
   
 98 
Schrag, J. D., Bergeron, J. J. M., Li, Y., Borisova, S., Hahn, M., Thomas, D. Y., & 
Cygler, M. (2001). The structure of calnexin, an ER chaperone involved in quality 
control of protein folding. Molecular Cell, 8(3), 633–644. 
https://doi.org/10.1016/S1097-2765(01)00318-5 
Serge Arnaudeau, Maud Frieden, Kim Nakamura, Cyril Castelbou, Marek Michalak,  and 
N. D. (2002). Calreticulin Differentially Modulates Calcium Uptake and Release in 
the Endoplasmic Reticulum and Mitochondria*, 277(48), 46696–46705. 
https://doi.org/10.1074/jbc.M202395200 
Sharma, N. K., Das, S. K., Mondal, A. K., Hackney, O. G., Chu, W. S., Kern, P. A., … 
Elbein, S. C. (2008). Endoplasmic reticulum stress markers are associated with 
obesity in nondiabetic subjects. The Journal of Clinical Endocrinology and 
Metabolism, 93(11), 4532–4541. https://doi.org/10.1210/jc.2008-1001 
Sierra-Honigmann, M. R. (1998). Biological Action of Leptin as an Angiogenic Factor. 
Science, 281(5383), 1683–1686. https://doi.org/10.1126/science.281.5383.1683 
Singhal, A. (2005). Endothelial dysfunction: role in obesity-related disorders and the 
early origins of CVD. Proceedings of the Nutrition Society, 64(1), 15–22. 
https://doi.org/10.1079/PNS2004404 
 
 
  
   
 99 
Spiro, R. G., Zhu, Q., Bhoyroo, V., & Söling, H. D. (1996). Definition of the lectin-like 
properties of the molecular chaperone, calreticulin, and demonstration of its 
copurification with endomannosidase from rat liver Golgi. Journal of Biological 
Chemistry, 271(19), 11588–11594. https://doi.org/10.1074/jbc.271.19.11588 
Szabo, E., Feng, T., Dziak, E., & Opas, M. (2009). Cell adhesion and spreading affect 
adipogenesis from embryonic stem cells: The role of calreticulin. Stem Cells, 27(9), 
2092–2102. https://doi.org/10.1002/stem.137 
Tang, W., Zeve, D., Suh, J. M., Bosnakovski, D., Kyba, M., Hammer, R. E., … Graff, J. 
M. (2008). White Fat Progenitor Cells Reside in the Adipose Vasculature. Science, 
322(5901), 583–586. https://doi.org/10.1126/science.1156232 
Tchkonia, T., Thomou, T., Zhu, Y., Karagiannides, I., Pothoulakis, C., Jensen, M. D., & 
Kirkland, J. L. (2013). Mechanisms and metabolic implications of regional 
differences among fat depots. Cell Metabolism. 
https://doi.org/10.1016/j.cmet.2013.03.008 
Trayhurn, P., & Beattie, J. H. (2001). Physiological role of adipose tissue: white adipose 
tissue as an endocrine and secretory organ. Proceedings of the Nutrition Society, 
60(3), 329–339. https://doi.org/10.1079/PNS200194 
 
 
  
   
 100 
Trombetta, E. S., Simons, J. F., & Helenius, A. (1996). Endoplasmic reticulum 
glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, 
and a tightly bound noncatalytic HDEL- containing subunit. Journal of Biological 
Chemistry, 271(44), 27509–27516. https://doi.org/10.1074/jbc.271.44.27509 
Wada, I., Imai, S. I., Kai, M., Sakane, F., & Kanoh, H. (1995). Chaperone function of 
calreticulin when expressed in the endoplasmic reticulum as the membrane-
anchored and soluble forms. Journal of Biological Chemistry. 
https://doi.org/10.1074/jbc.270.35.20298 
White, T. K., Zhu, Q., & Tanzer, M. L. (1995). Cell surface calreticulin is a putative 
mannoside lectin which triggers mouse melanoma cell spreading. Journal of 
Biological Chemistry, 270(27), 15926–15929. 
https://doi.org/10.1074/jbc.270.27.15926 
WHO. (2012). WHO | Obesity and overweight. World Health Organisation Media 
Centre Fact Sheet No. 311, 1–2. Retrieved from 
http://www.who.int/mediacentre/factsheets/fs311/en/#.U2gDIH5zIZ4.mendeley 
Wilcox, G. (2005). Insulin and insulin resistance. The Clinical Biochemist. Reviews / 
Australian Association of Clinical Biochemists, 26(2), 19–39. 
https://doi.org/10.1016/S0025-7125(03)00128-7 
 
 
  
   
 101 
Winrow, C. J., Miyata, K. S., Marcus, S. L., Burns, K., Michalak, M., Capone, J. P., & 
Rachubinski, R. A. (1995). Calreticulin Modulates the in-Vitro DNA-Binding but 
Not the in-Vivo Transcriptional Activation by Peroxisome Proliferator-Activated 
Receptor Retinoid-X Receptor Heterodimers. Molecular and Cellular 
Endocrinology, 111(2), 175–179. 
Witting, P. K., Rayner, B. S., Wu, B. J., Ellis, N. A., & Stocker, R. (2007). Hydrogen 
peroxide promotes endothelial dysfunction by stimulating multiple sources of 
superoxide anion radical production and decreasing nitric oxide bioavailability. 
Cellular Physiology and Biochemistry, 20(5), 255–268. 
https://doi.org/10.1159/000107512 
Xue, Y., Petrovic, N., Cao, R., Larsson, O., Lim, S., Chen, S., … Cao, Y. (2009). 
Hypoxia-Independent Angiogenesis in Adipose Tissues during Cold Acclimation. 
Cell Metabolism, 9(1), 99–109. https://doi.org/10.1016/j.cmet.2008.11.009 
Yokoyama, M., & Hirata, K. I. (2005). New function of calreticulin: Calreticulin-
dependent mRNA destabilization. Circulation Research, 97(10), 961–963. 
https://doi.org/10.1161/01.RES.0000193564.46466.2a 
Zapun, A., Darby, N. J., Tessier, D. C., Michalak, M., Bergeron, J. J. M., & Thomas, D. 
Y. (1998). Enhanced catalysis of ribonuclease B folding by the interaction of 
calnexin or calreticulin with ERp57. Journal of Biological Chemistry, 273(11), 
6009–6012. https://doi.org/10.1074/jbc.273.11.6009 
  
   
 102 
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L. N., Kirby, M., Mostowski, H., 
& Quon, M. J. (2000). Roles for insulin receptor, PI3-kinase, and Akt in insulin-
signaling pathways related to production of nitric oxide in human vascular 
endothelial cells. Circulation, 101(13), 1539–1545. 
https://doi.org/10.1161/01.CIR.101.13.1539 
 
  
   
 103 
APPENDIX A: Ethical Approval   
 
  
   
 401 
  cibarA ni detalsnart tcartsbA :B XIDNEPPA
 ةنمسلا ریوطت يف ببستت ةیلآك ةیومدلا ةیعولأا ةناطب لخاد للخ
 ةماعلا ةحصلا نم ریرقت رخلآ ًاقفوو .اھراشتنا يف ةعیرس ةدایز عم ملاعلا يف ةماعلا ةحصلا ایاضق مھأ نم ةدحاو ةنمسلا ربتعت
 نكمی ثیح يھ ةینھدلا ایلاخلا .لاجرلا ىدل ٪3.86 ـب ةنراقم ٪8.17 ءاسنلا ىدل ةنادبلا ةبسن تناك ،2102 ماع يف رطق يف ایلعلا
 .اھعسوت معدل ةیلاع ةیومد ةیعوأ دوجو بلطتی ةینھدلا ةجسنلأا يف عیرسلا عسوتلا .ماعطلا لوخدم فلاتخاب اھمجح فلتخی نأ
 يف امب ةفلتخم ضارمأ نع ریراقتلا نم دیدعلا رادصا مت .حیحص لكشب ةیناطبلا ایلاخلا لمع ىلع دمتعی ةیومدلا ةیعولأا عرفت
 يف تاریغتلا ببسب بیعلا اذھ نوكی نأ نكمی .ةیناطبلا ةیلخلا ةفیظو يف بویع اھببس ناك يتلاو ةنمسلاو يركسلا ضرم كلذ
 .ةجسنلأا فلت ىلإ يدؤی امم ىرخلأا سلاكیداریسكولأا جاتنإ وأ ةیومدلا ةیعولأا ضابقنا مظنی يذلا دیسكأ كیرتینلا جاتنإ
 اذھل ةیسیئرلا فئاظولا .تاییدثلا ایلاخ لكل ةیمزلابودنلاا ةكبشلا يف دجوی فئاظولا ددعتم نیتورب وھ )TRC( niluciterlaC 
 ةیناطبلا ایلاخلا يف TRC desserpxerevo ةساردلا هذھ يف ایثارو ةلدعملا نارئفلا جذومن رھظأ .ایلاخلا میظنت يھ نیتوربلا
 ،كلذل .نسلا يف نارئفلا هذھ مدقت عم يركسلا ضرمو ةنمسلل ةیلباقلاو ةیناطبلا ایلاخلا يف يفیظو للخ ىلع ةلدأ(CE+ TRC)
 طیشنت ىلإ يدؤی امم يئاعولا عرفتلا نم دیزی يناطب يفیظو للخ ىلإ يدؤی ةیناطبلا ایلاخلا يف TRC يف طارفلإا نأ انضرتفا
 .نوھدلا نیوكت ةیلمع
 مھتیذغت تمت ثیح CE+ TRC  و  tw نارئفلا نم ًلاك يف ةینھدلا ایلاخلل نزولا يف ةیرھاظلا تارییغتلا انسرد ةساردلا هذھ يف
 نارئفلا هذھ نأ اھیلإ انلصوت يتلا جئاتنلا ترھظأ .(عیباسأ 42-8) ةفلتخم ةینمز ةرتفل (٪ 01) ةیداعلا نوھدلا وأ (٪ 06) نوھدلا
 TTG مدلا يف ركسلا تاصوحف تحضوأ .ةیناطبلا ایلاخلا ةفیظو يف فعض ىلإ يدؤی امم يعیبطلا نم  لقأ  SONe ةبسن اھیدل
 نوھدلاب ينغ يئاذغ ماظن ىلع ،كلذ عمو .نوھدلا نم ٪01 لوانت دنع رمعلا مدقت عم يركسلا ضرم تروط CE+ TRC نارئف نأ
 تارییغت   tw و CE+ TRC نارئفلا نم ًلاكل نزولل يجیسنلا لیلحتلا رھظأ .عیباسأ 8 يف ىتح مدلا يف ركسلا يوتسم میظنت يف اولشف
 ببست يذلا للخلاو ةیناطبلا ایلاخلا يف TRC  نیتورب ةدایز نیب طابترا دوجو ىلإ ریشی امل اھددعو ةینھدلا ایلاخلا مجح يف ةریبك
 رییغت يف ةینطابلا ةیلاخلا ةفیظو للخل مھملا رودلا رھظت يتلا ىلولأا يھ انتسارد .نوھدلا نیوكت ةفیظو نیبو اھتفیظو للخ يف
 تانیتوربلا دوجو ةیمھأ ىلع ءوضلا انتانایب طلست امك .يركسلا ضرمو ةنمسلا روطت ىلإ يدؤت يتلا نوھدلا نیوكت ةیلمع
  .ةیلمعلا هذھ يف ةیمزلابودنلاا ةكبشلا يف ةدوجوملا
 
